Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications
Tóm tắt
Từ khóa
Tài liệu tham khảo
Benson K, Hartz AJ: A comparison of observational studies and randomized, controlled trials. N Engl J Med 342: 1878–1886, 2000
Concato J, Sihah N, Horwitz RI: Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887–1892, 2000
American Diabetes Association Special Report: Principles of nutrition and dietary recommendations for patients with diabetes mellitus: 1971. Diabetes 20:633–634, 1971
American Diabetes Association Special Report: Principles of nutrition and dietary recommendations for individuals with diabetes mellitus: 1979. Diabetes 28:1027–1030, 1979
American Diabetes Association: Nutrition recommendations and principles for individuals with diabetes mellitus: 1986. Diabetes Care 10:126–132, 1987
American Diabetes Association: Nutrition recommendations and principles for people with diabetes mellitus (Position Statement). Diabetes Care 17:519–522, 1994
Franz MJ, Horton ES, Bantle JP, Beebe CA, Brunzell JD, Coulston AM, Henry RR, Hoogwerf BJ, Stacpoole PW: Nutrition principles for the management of diabetes and related complications. Diabetes Care 17:490–518, 1994
American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 25(Suppl. 1): S33–S49, 2002
American Diabetes Association Provider Recognition Program: Available from http:/www.diabetes.org/recognition/Provider. Accessed January 2001
Mensing C, Boucher J, Cypress M, Weinger K, Mulcahy K, Barta P, Hosey G, Kopher W, Lasichak A, Lamb B, Mangan M, Norman J, Tanja J, Yauk L, Wisdom K, Adams C: National standards for diabetes self-management education (Standards and Review Criteria). Diabetes Care 23:682–689, 2000
Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986, 1993
U.K. Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853, 1998
Delahanty LM, Halford BH: The role of diet behaviors in achieving improved glycemic control in intensively treated patients in the Diabetes Control and Complications Trial. Diabetes Care 16:1453–1458, 1993
UKPDS Group: UK Prospective Diabetes Study 7: Response of fasting plasma glucose to diet therapy in newly presenting type II patients with diabetes. Metabolism 39:905–912, 1990
Haffner SM: Management of dyslipidemia in adults with diabetes (Technical Review). Diabetes Care 21:160–178, 1998
U.S. Department of Agriculture, U.S. Department of Health and Human Services: Nutrition and Your Health: Dietary Guidelines for Americans. 5th ed. Home and Garden Bulletin No. 232, 2000
Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman JW, Kris-Etherton P, Goldberg IJ, Kotchen TA, Lichtenstein AH, Mitch WE, Mullis R, Robinson K, Wylie-Rosett J, St. Jeor S, Suttie J, Tribble DL, Bazzarre TL: AHA Dietary Guidelines Revision 2000: a statement for health care professionals from the Nutrition Committee of the American Heart Association. Circulation 102:2284–2299, 2000
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486–2497, 2001
de Chavez M, Chavez A: Diet that prevents cancer: recommendations from the American Institute for Cancer Research. Int J Cancer Suppl 11:85–89, 1998
The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157:2412–2446, 1997
Kant AK, Schatzkin A, Graubard BI, Schairer C: A prospective study of diet quality and mortality in women. JAMA 283:2109–2115, 2000
Hu FB, Rimm EB, Stampfer MJ, Ascherio A, Spiegelman D, Willett WC: Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr 72:912–921, 2000
Huijbregts P, Feskens E, Rasanen L, Fidanza F, Nissinen A, Menotti A, Kromhout D: Dietary patterns and 20 year mortality in elderly men in Finland, Italy, and The Netherlands: longitudinal cohort study. BMJ 315:13–17, 1997
Appel LJ, Moore TJ, Obarzanek E, Vollmer VW, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N: A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336:1117–1124, 1997
Anderson JW, Hanna TJ, Peng X, Kryscio RJ: Whole grain food and heart disease risk. J Am Coll Nutr 19:291S–299S, 2000
Liu S, Manson JE, Lee I-M, Cole SR, Hennekens CH, Willett WC, Buring JE: Fruit and vegetable intake and risk of cardiovascular disease: the Women’s Health Study. Am J Clin Nutr 72:922–928, 2000
Liu S, Manson JE, Stampfer MJ, Hu FB, Giovannucci E, Colditz GA, Hennekens CH, Willett WC: A prospective study of whole-grain intake and risk of type 2 diabetes mellitus in U.S. women. Am J Public Health 90:1409–1415, 2000
Institute of Medicine: The Role of Nutrition in Maintaining Health in the Nation’s Elderly: Evaluating Coverage of Nutrition Services for the Medicare Population. Washington, DC, National Academy Press, 2000
Kulkarni K, Castle G, Gregory R, Holmes A, Leontos C, Power M, Snetselar L, Splett P, Wylie-Rosett J, for the Diabetes Care and Education Dietetic Practice Group: Nutrition practice guidelines for type 1 diabetes mellitus positively affect dietitian practices and patient outcomes. J Am Diet Assoc 98:62–70, 1998
Franz MJ, Monk A, Barry B, McLain K, Weaver T, Cooper N, Upham P, Bergenstal R, Mazze R: Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: a randomized, controlled clinical trial. J Am Diet Assoc 95:1009–1017, 1995
Christensen NK, Steiner J, Whalen J, Pfister R: Contribution of medical nutrition therapy and diabetes self-management education to diabetes control as assessed by hemoglobin A1c. Diabetes Spectrum 13:72–75, 2000
Eely EA, Stratton IM, Haddon DR, Turner RC, Holman RR, on behalf of the U.K. Prospective Diabetes Study Group: UKPDS 18: estimated dietary intake in type 2 patients with diabetes randomly allocated to diet, sulphonylurea or insulin therapy. Diabet Med 13:656–662, 1996
Franz MJ, Splett PL, Monk A, Barry B, McLain K, Weaver T, Upham P, Bergenstal R, Mazze RS: Cost effectiveness of medical nutrition therapy provided by dietitians for persons with non-insulin-dependent diabetes. J Am Diet Assoc 95:1018–1024, 1995
Johnson EQ, Valera S: Medical nutrition therapy in non-insulin-dependent diabetes mellitus improves clinical outcomes. J Am Diet Assoc 95:700–701, 1995
Hebert JR, Ebbeling CB, Ockene IS, Ma Y, Rider L, Merriam PA, Ockene JK, Saperia GM: A dietitian-delivered group nutrition program leads to reductions in dietary fat, serum cholesterol, and body weight: the Worcester Area Trial for Counseling in Hyperlipidemia (WATCH). J Am Diet Assoc 99:544–552, 1999
Delahanty LM, Sonnenberg LM, Hayden D, Nathan DM: Clinical and cost outcomes of medical nutrition therapy for hypercholesterolemia: a controlled trial. J Am Diet Assoc 101:1012–1023, 2001
Rhodes KS, Bookstein LC, Aaronson LS, Mercer NM, Orringer CE: Intensive nutrition counseling enhances outcomes of National Cholesterol Education Program dietary therapy. J Am Diet Assoc 96:1003–1010, 1996
Caggiula AW, Watson JE, Kuller LH, Olson MB, Milas NC, Berry M, Germanowski J: Cholesterol-Lowering Intervention Program: effect of the step I diet in community office practices. Arch Intern Med 156:1205–1213, 1996
Henkin Y, Shai I, Zuk R, Brickner D, Avilli I, Neuman L, Shany S: Dietary treatment of hypercholesterolemia: Do dietitians do it better? a randomized, controlled trial. Am J Med 109:549–555, 2000
Sikand G, Kashyap ML, Yang I: Medical nutrition therapy lowers serum cholesterol and saves medication costs in men with hypercholesterolemia. J Am Diet Assoc 98:889–894, 1998
Sikand G, Kashyap ML, Wong ND, Hsu JC: Dietitian intervention improves lipid values and saves medication costs in men with combined hyperlipidemia and a history of niacin noncompliance. J Am Diet Assoc 100:218–222, 2000
Diabetes Control and Complications Trial Research Group: Expanded role of the dietitian in the Diabetes Control and Complications Trial: implications for practice. J Am Diet Assoc 93:758–767, 1993
Diabetes Control and Complications Trial Research Group: Implementation protocols in the Diabetes Control and Complications Trial. Diabetes Care 18:361–376, 1995
Glasgow RE, Toobert DJ, Hampson SE, Brown JE, Lewinsohn PM, Donnelly J: Improving self-care among older patients with type II diabetes: the “Sixty Something. . .” study. Patient Educ Couns 19:61–74, 1992
Sadur CN, Moline N, Costa M, Michalik D, Mendlowitz D, Roller S, Watson R, Swain BE, Selby JV, Javorski WC: Diabetes management in a health maintenance organization. Diabetes Care 22:2011–2017, 1999
Report of a Joint FAO/WHO Expert Consultation: Carbohydrates in Human Nutrition. Rome, Italy, Food and Agriculture Organization of the United Nations and World Health Organization, 1998
Gannon MC, Nuttall FQ, Westphal SA, Fang D, Ercan-Fang N: Acute metabolic response to high-carbohydrate, high-starch meals compared with moderate-carbohydrate, low-starch meals in subjects with type 2 diabetes. Diabetes Care 21:1619–1626, 1998
Wolever TMS, Nguyen P-M, Chiasson J-L: Determinants of diet glycemic index calculated retrospectively from diet records of 342 individuals with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 59:1265–1269, 1994
O’Dea K, Snow P, Nestel P: Rate of starch hydrolysis in vitro as a predictor of metabolic responses to complex carbohydrate in vivo. Am J Clin Nutr 34:1991–1993, 1981
Snow P, O’Dea K: Factors affecting the rate of hydrolysis of starch in food. Am J Clin Nutr 34:2721–2727, 1981
Jarvi A, Karlstrom B, Granfeldt Y, Bjorck I, Vessby B: The influence of food structure on postprandial metabolism in patients with NIDDM. Am J Clin Nutr 61:837–842, 1995
Hughes TA, Atchison J, Hazelrig JB, Boshell BR: Glycemic responses in insulin-dependent patients with diabetes: effect of food composition. Am J Clin Nutr 49:658–666, 1989
Nielsen PH, Nielsen GL: Preprandial blood glucose values: influence on glycemic response studies. Am J Clin Nutr 53:1243–1246, 1989
Rasmussen I, Hermansen K: Preprandial blood glucose values and glycemic responses in insulin-dependent diabetes mellitus at constant insulinemia. Am J Clin Nutr 53:520–523, 1991
Fraser RJ, Horowitz M, Maddox AF, Harding PE, Chatterton BE, Dent J: Hyperglycemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 33:675–680, 1990
Schvarcz E, Palmer M, Aman J, Lindkvist B, Beckman K-W: Hypoglycaemia increases gastric emptying rate in patients with type 1 diabetes mellitus. Diabet Med 10:660–663, 1993
Parillo M, Giacco R, Ciardullo AV, Rivellese AA, Riccardi G: Does a high-carbohydrate diet have different effects in NIDDM patients treated with diet alone or hypoglycemic drugs? Diabetes Care 19:498–500, 1996
Jenkins DHA, Wolever TMS, Taylor RH, Griffiths C, Krzeminska K, Lawrie JA, Bennett CM, Goff DV, Sarson DL, Bloom SR: Slow release carbohydrate improves second meal tolerance. Am J Clin Nutr 35:1339–1346, 1982
Perrotti N, Santoro D, Genovese S, Giacco A, Rivellese A, Riccardi G: Effect of digestible carbohydrates on glucose control in insulin-dependent patients with diabetes. Diabetes Care 7:354–359, 1984
Strychar IM, Blain E, Rivard M, Gélinas MD, Radwan F, Crawhall JC: Association between dietary adherence measures and glycemic control in outpatients with type 1 diabetes mellitus and normal serum lipid levels. J Am Diet Assoc 98:76–79, 1998
Georgopoulous A, Bantle JP, Noutsou M, Swaim WR, Parker SJ: Differences in the metabolism of postprandial lipoproteins after a high-monounsaturated-fat versus a high-carbohydrate diet in patients with type 1 diabetes mellitus. Arterioscler Thromb Vasc Biol 18:773–782, 1998
Forlani G, Galuppi V, Santacroce G, Braione AF, Giangiulio S, Ciavarella A, Vannini P: Hyperglycemic effect of sucrose ingestion in IDDM patients controlled by artificial pancreas. Diabetes Care 12:296–298, 1989
Hassinger W, Sauer G, Cordes U, Krause U, Beyer J, Baessler KH: The effects of equal caloric amounts of xylitol, sucrose and starch on insulin requirements and blood glucose levels in insulin-dependent diabetics. Diabetologia 21:37–40, 1981
Loghmani E, Rickard K, Washburne L, Vandagriff J, Fineberg N, Golden M: Glycemic response to sucrose-containing mixed meals in diets of children with insulin-dependent diabetes mellitus. J Pediatr 119:531–537, 1991
Steel JM, Mitchell D, Prescott RL: Comparison of the glycaemic effect of fructose, sucrose and starch-containing mid-morning snacks in insulin-dependent diabetics. Hum Nutr Appl Nutr 37:3–8, 1983
Wheeler ML, Fineberg E, Gibson R, Fineberg N: Controlled portions of presweetened cereals present no glycemic penalty in persons with insulin-dependent diabetes mellitus. J Am Diet Assoc 96:458–463, 1996
Slama G, Haardt MJ, Jean-Joseph P, Costagliola D, Goicolea I, Bornet F, Elgrably F, Tchobroutsky G: Sucrose taken during mixed meal has no additional hyperglycemic action over isocaloric amounts of starch in well-controlled diabetics. Lancet i i:122–125, 1984
Rickard KA, Loghmani E, Cleveland JL, Fineberg NS, Greidenberg GR: Lower glycemic response to sucrose in the diets of children with type 1 diabetes. J Pediatr 133:429–432, 1998
Bantle JP, Laine DC, Thomas JW: Metabolic effects of dietary fructose and sucrose in type I and II diabetic subjects. JAMA 256:3241–3246, 1986
Venhaus A, Chanteleau E: Self-selected unrefined and refined carbohydrate diets do not affect metabolic control in pump-treated patients with diabetes. Diabetologia 31:153–157, 1988
Peterson DB, Lambert J, Gerring S, Darling P, Carter RD, Jelfs R, Mann JI: Sucrose in the diet of patients with diabetes–just another carbohydrate? Diabetologia 29:216–220, 1986
Wise JE, Keim KS, Huisinga JL, Willmann PA: Effect of sucrose-containing snacks on blood-glucose control. Diabetes Care 12:423–426, 1989
Rabasa-Lhoret R, Garon J, Langelier H, Poisson D, Chiasson J-L: The effects of meal carbohydrate content on insulin requirements in type 1 patients with diabetes treated intensively with the basal bolus (ultralente-regular) insulin regimen. Diabetes Care 22:667–673, 1999
Hamet P, Abarca G, Lopez D, Hamet M, Bourque M, Peyronnard J-M, Charron L, Larochelle P: Patient self-management of continuous subcutaneous insulin infusion. Diabetes Care 5:485–491, 1982
Heinemann L, Heise T, Wahl LC, Trautmann ME, Ampudia J, Starke AAR, Berger M: Prandial glycaemia after a carbohydrate-rich meal in type 1 patients with diabetes: using the rapid acting insulin analogue [Lys(B28),Pro(B29)] human insulin. Diabet Med 13:625–629, 1996
Slama G, Klein JC, Delage A, Ardila E, Lemaignen H, Papoz L, Tchobroutsky G: Correlation between the nature and amount of carbohydrate in meal intake and insulin delivery by the artificial pancreas in 24 insulin-dependent diabetics. Diabetes 30:101–105, 1981
Wolever TMS, Hamad S, Chiasson J-L, Josse RG, Leiter LA, Rodger NW, Ross SA, Ryan EA: Day-to-day consistency in amount and source of carbohydrate intake associated with improved glucose control in type 1 diabetes. J Am Coll Nutr 18:242–247, 1999
Collier GR, Giudici S, Kalmusky J, Wolever TMS, Helman G, Wesson V, Ehrlich RM, Jenkins DJA: Low glycaemic index starchy food improve glucose control and lower serum cholesterol in diabetic children. Diabetes Nutr Metab 1:11–19, 1988
Fontvieille AM, Acosta M, Rizkalla SW, Bornet F, David P, Letanoux M, Tchobroutsky G, Slama G: A moderate switch from high to low glycaemic-index food for 3 weeks improves the metabolic control of type I (IDDM) diabetic subjects. Diabetes Nutr Metab 1:139–143, 1988
Fontvieille AM, Rizkalla SW, Penfornis A, Acosta M, Bornet FR, Slama G: The use of low glycaemic index food improves metabolic control of patients with diabetes over five weeks. Diabet Med 9:444–450, 1992
Lafrance L, Rabasa-Lhoret R, Poisson D, Ducros F, Chiasson J-L: The effects of different glycaemic index food and dietary fibre intake on glycaemic control in type 1 patients with diabetes on intensive insulin therapy. Diabet Med 15:972–978, 1998
Calle-Pascual AL, Gomez V, Leon E, Bordiu E: Food with a low glycemic index do not improve glycemic control of both type 1 and type 2 patients with diabetes after one month of therapy. Diabetes Metab 14:629–633, 1988
Buyken AE, Toeller M, Heitkamp G, Karamanos B, Rottiers R, Muggeo M, Fuller JH, EURODIAB IDDM Complications Study Group: Glycemic index in the diet of European outpatients with type 1 diabetes: relations to glycated hemoglobin and serum lipids. Am J Clin Nutr 73:574–581, 2001
Vaaler S, Hanssen KF, Aagenaes O: Effect of different kinds of fibre on postprandial blood glucose in insulin-dependent diabetics. Acta Med Scand 208:389–391, 1980
Chenon D, Mbumba P, Monnier LH, Colette C, Orsetti A, Mirouze J: Effects of dietary fiber on postprandial glycemic profiles in patients with diabetes submitted to continuous programmed insulin infusion. Am J Clin Nutr 40:58–65, 1984
Riccardi G, Rivellese A, Pacioni D, Genovese S, Mastranzo P, Mancini M: Separate influence of dietary carbohydrate and fibre on the metabolic control in diabetes. Diabetologia 26:116–121, 1984
Nygren C, Hallmans G, Lithner F: Effects of high-bran bread on blood glucose control in insulin-dependent patients with diabetes. Diabetes Metab 10:39–43, 1984
Giacco R, Parillo M, Rivellese AA, Lasorellla G, Giacco A, D’Episcopo L, Riccardi G: Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural food improves blood glucose control and reduces the number of hypoglycemic events in type 1 patients with diabetes. Diabetes Care 23:1461–1466, 2000
Toeller M, Buyken AE, Heitkamp G, de Pergola G, Giorgino F, Fuller JH, The EURODIAB IDDM Complications Study Group: Fiber intake, serum cholesterol levels, and cardiovascular disease in European individuals with type 1 diabetes. Diabetes Care 22(Suppl. 2):B21–B28, 1999
Garg A, Bantle JP, Henry RR, Coulston AM, Griver KA, Raatz SK, Brinkley L, Chen Y-D I, Grundy SM, Huet BA, Reaven GM: Effects of varying carbohydrate content of diet in patients with non-insulin dependent diabetes mellitus. JAMA 271:1421–1428, 1994
Garg A: High-monounsaturated fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 67:577S–582S, 1998
Manson JE, Spelsberg A: Primary prevention of non-insulin-dependent diabetes mellitus. Am J Prev Med 10:172–184, 1994
Marshall JA, Bessesen DH, Hamman RF: High saturated fat and low starch and fiber are associated with hyperinsulinaemia in a non-diabetic population: the San Luis Valley Diabetes Study. Diabetologia 40:430–438, 1997
Feskens EJ, Loeber JG, Kromhout D: Diet and physical activity as determinants of hyperinsulinemia: the Zutphen Elderly Study. Am J Epidemiol 140:350–360, 1994
Folsom AR, Ma J, McGovern PG, Eckfeldt H: Relation between plasma phospholipid saturated fatty acids and hyperinsulinemia. Metabolism 45:223–228, 1996
Lovejoy JC, DiGirolamo M: Habitual dietary intake and insulin sensitivity in lean and obese adults. Am J Clin Nutr 55:1174–1179, 1992
Lovejoy JC, Windhauser MM, Rood JC, de la Bretonne JA: Effect of a controlled high-fat versus low-fat diet on insulin sensitivity and leptin levels in African-American and Caucasian women. Metabolism 47:1520–1524, 1998
Mayer EJ, Newman B, Quesenberry CP Jr, Selby JV: Usual dietary fat intake and insulin concentrations in healthy women twins. Diabetes Care 16:1459–1469, 1993
Mayer-Davis EJ, Monaco JH, Hoen HM, Carmichael S, Vitolins MZ, Rewers MJ, Haffner SM, Ayad MF, Bergman RN, Karter AJ: Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study. Am J Clin Nutr 65:79–87, 1997
Maron DJ, Fair JM, Haskell WL: Saturated fat intake and insulin resistance in men with coronary artery disease. Circulation 84:2070–2074, 1991
Bantle JP, Laine DC, Castle GW, Thomas JW, Hoogwerf BJ, Goetz FG: Postprandial glucose and insulin responses to meals containing different carbohydrates in normal and diabetic subjects. N Engl J Med 309:7–12, 1983
Hollenbeck CB, Coulston AM, Donner CC, Williams RA, Reaven GM: The effects of variations in percent of naturally occurring complex and simple carbohydrates on plasma glucose and insulin response in individuals with non-insulin-dependent diabetes mellitus. Diabetes 34:151–155, 1985
Abraira C, Derler J: Large variations of sucrose in constant carbohydrate diets in type II diabetes. Am J Med 84:193–200, 1988
Bantle JP, Swanson JE, Thomas W, Laine DC: Metabolic effects of dietary sucrose in type II diabetic subjects. Diabetes Care 16:1301–1305, 1993
Colagiuir S, Miller JJ, Edwards RA: Metabolic effects of adding sucrose and aspartame to the diet of subjects with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 50:474–478, 1989
Malerbi DA, Paiva ES, Duarte AL, Wajchenberg BL: Metabolic effects of dietary sucrose and fructose in type 2 diabetic subjects. Diabetes Care 19:1249–1256, 1996
Brand JC, Colagiuri S, Crossman S, Allen A, Roberts DCK, Truswell AS: Low glycemic index food improve long-term glycemic control in NIDDM. Diabetes Care 14:95–101, 1991
Jenkins DJA, Wolever TMS, Buckley G, Lam KY, Giudici S, Kalmusky J, Jenkins AL, Patten RL, Bird J, Wong GS, Josse RG: Low-glycemic index starchy food in the diabetic diet. Am J Clin Nutr 48:248–254, 1988
Luscombe ND, Noakes M, Clifton PM: Diets high and low in glycemic index versus high monounsaturated fat diets: effects on glucose and lipid metabolism in NIDDM. Eur J Clin Nutr 53:473–478, 1999
Wolever TMS, Jenkins DJA, Vuksan V, Jenkins AL, Wong GS, Josse RG: Beneficial effects of low-glycemic index diet in overweight NIDDM. Diabetes Care 15:562–564, 1992
Wolever TMS, Jenkins DJA, Vuksan V, Jenkins AL, Buckley GC, Wong GS, Josse RG: Beneficial effect of low-glycaemic index diet in type 2 diabetes. Diabet Med 9:451–458, 1992
Jarvi A, Karlstrom B, Granfeldt Y, Bjorck I, Asp NG, Vessby B: Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low glycemic index diet in type 2 patients with diabetes. Diabetes Care 22:10–18, 1999
Frost G, Wilding S, Beecham J: Dietary advice based on the glycaemic index improves dietary profiles and metabolic control in type 2 patients with diabetes. Diabet Med 11:397–401, 1994
Frost G, Leeds AA, Doré CJ, Madeiros S, Brading S, Domhorst A: Glycaemic index as a determinant of serum HDL cholesterol concentration. Lancet 353:1045–1048, 1999
Ford ES, Liu S: Glycemic index and serum high-density lipoprotein cholesterol concentration among US adults. Arch Intern Med 161:572–576, 2001
Frost G, Leeds A, Trew G, Margara R, Dornhorst A: Insulin sensitivity in women at risk of coronary heart disease and effect of a low glycemic index diet. Metabolism 47:1245–1251, 1998
Frost G, Keogh B, Smith D, Akinsanya K, Leeds A: The effect of low-glycemic carbohydrate on insulin and glucose response in vivo and in vitro in patients with coronary heart disease. Metabolism 45:669–672, 1996
Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, Stampfer MJ, Wing AL, Willett WC: Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 20:545–550, 1997
Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC: Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 277:472–477, 1997
Liu S, Willett WC, Stampfer MJ, Hu FB, Franz M, Sampson L, Hennekens CH, Manson JE: A prospective study of dietary glycemic load, carbohydrate intake and risk of coronary heart disease in US women. Am J Clin Nutr 71:1455–1461, 2000
Liu S, Manson JE, Stampfer MJ, Holmes MD, Hu FB, Hankinson SE, Willett WC: Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women. Am J Clin Nutr 73:560–566, 2001
Hollenbeck CB, Coulston AM, Reaven GM: To what extent does increased dietary fiber improve glucose and lipid metabolism in patients with noninsulin-dependent diabetes mellitus (NIDDM)? Am J Clin Nutr 43:16–24, 1986
Jenkins DJA, Leeds AR, Gassull MA, Wolever TMS, Goff DV, Alberti KGMM, Hockaday TDR: Unabsorbable carbohydrates and diabetes: decreased postprandial hyperglycemia. Lancet i i:172–174, 1976
Chandalia M, Garg A, Luthohann D, von Bergmann K, Grundy SM, Brinkley LJ: Beneficial effects of a high dietary fiber intake in patients with type 2 diabetes. N Engl J Med 342:1392–1398, 2000
Brown L, Rosner B, Willett WW, Sacks FM: Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 69:30–42, 1999
Anderson JW, Allgood LD, Turner J, Oeltgen PR, Daggy BP: Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia. Am J Clin Nutr 70:466–473, 1999
Tappy L, Gugolz E, Wursch P: Effects of breakfast cereals containing various amounts of B-glucan fibers on plasma glucose and insulin responses in NIDDM subjects. Diabetes Care 19:831–834, 1996
Bourdon I, Yokoyama W, Davis P, Hudson C, Backus R, Richter D, Knuckles B: Postprandial lipid, glucose, insulin, and cholecystokinin responses in men fed barley pasta enriched with B-glucan. Am J Clin Nutr 69:55–63, 1999
Gibney M, Sigman-Grant M, Stanton JL, Keast DR: Consumption of sugars. Am J Clin Nutr 62 (Suppl.):178S−194S, 1995
Bornet F, Haardt MJ, Costagliola D, Blayo A, Slama G: Sucrose or honey at breakfast have no additional acute hyperglycaemic effect over an isoglucidic amount of bread in type 2 diabetes patients. Diabetologia 28:213–217, 1985
Rickard KA, Cleveland JL, Loghmani EB, Fineberg NS, Freidenberg GR: Similar glycemic responses to high versus moderate sucrose-containing food in test meals for adolescents with type 1 diabetes and fasting euglycemia. J Am Diet Assoc 101:1202–1205, 2001
Nadeau J, Koski KG, Strychar I, Yale J-F: Teaching subjects with type 2 diabetes how to incorporate sugar choices into their daily meal plan promotes dietary compliance and does not deteriorate metabolic profile. Diabetes Care 24:222–227, 2001
Sigman-Grant M, Keast DR: Addendum to Am J Clin Nutr 62 (Suppl.):178S−194S, 1995. Am J Clin Nutr 65:1572–1574, 1997
Park YK, Yetley EA: Intakes and food sources of fructose in the United States. Am J Clin Nutr 58 (Suppl):737S−747S, 1993
Crapo PA, Kolterman OG, Henry RR: Metabolic consequence to two-week fructose feeding in diabetic subjects. Diabetes Care 9:111–119, 1986
Bantle JP, Swanson JE, Thomas W, Laine DC: Metabolic effects of dietary fructose in diabetic subjects. Diabetes Care 15:1468–1476, 1992
Hallfrisch J, Reiser S, Prather ES: Blood lipid distribution of hyperinsulinemic men consuming three levels of fructose. Am J Clin Nutr 37:740–748, 1983
Reiser S, Powell AS, Scholfield DJ, Panda P, Ellwood KC, Canary JJ: Blood lipids, lipoproteins, apoproteins, and uric acid in men fed diets containing fructose or high-amylose cornstarch. Am J Clin Nutr 49:832–839, 1989
Swanson JE, Laine DC, Thomas W, Bantle JP: Metabolic effects of dietary fructose in healthy subjects. Am J Clin Nutr 55:851–856, 1992
Bantle JP, Raatz SK, Thomas W, Georgopoulos A: Effects of dietary fructose on plasma lipids in healthy subjects. Am J Clin Nutr 72:1128–1134, 2000
Natah SS, Hussien KR, Tuominen JA, Koivisto VA: Metabolic response to lactitol and xylitol in healthy men. Am J Clin Nutr 65:947–950, 1997
Ishikawa M, Miyashita M, Kawashima Y, Nakamura T, Saitou N, Modderman J: Effects of oral administration of erythritol on patients with diabetes. Regul Toxicol Pharmacol 24:S303–S308, 1996
Vernia P, Frandina C, Bolotta T, Ricciardi MR, Vollotti G, Fallucca F: Sorbitol malabsorption and nonspecific abdominal symptoms in type II diabetes. Metabolism 44:796–799, 1995
Wheeler ML, Fineberg SE, Gibson R, Fineberg N: Metabolic response to oral challenge of hydrogenated starch hydrolysates versus glucose in diabetes. Diabetes Care 13:733–740, 1990
Vaaler S, Bjorneklett A, Jelling I, Skrede G, Hanssen KG, Fausa O, Aagenaes O: Sorbitol as a sweetener in the diet of insulin-dependent diabetes. Acta Med Scand 221:165–170, 1987
Akgun S, Ertel NH: A comparison of carbohydrate metabolism after sucrose, sorbitol, and fructose meals in normal and diabetic subjects. Diabetes Care 3:582–585, 1980
Payne ML, Craig WJ, Williams AC: Sorbitol is a possible risk factor for diarrhea in young children. J Am Diet Assoc 97:532–534, 1997
Jain NK, Rosenberg DB, Ulahannan MJ, Glasser MJ, Pitchumoni CS: Sorbitol intolerance in adults. J Gastroenterol 80:678–681, 1985
Englyst HN, Veenstra J, Hudson GJ: Measurement of rapidly available glucose (RAG) in plant food: a potential in vitro predictor of the glycemic response. Br J Nutr 75:327–337, 1996
Hoebler C, Karinthi A, Chiron H, Champ M, Barry J-L: Bioavailability of starch in bread rich in amylose: metabolic responses in healthy subjects and starch structure. Eur J Clin Nutr 53:360–366, 1999
Granfeldt Y, Drews A, Björck I: Arepas made from high amylose starch corn flour produce favorably low glucose and insulin responses in healthy humans. J Nutr 125:459–465, 1995
Raben A, Tagliabue A, Christensen NJ, Madsen J, Holst JJ, Astrup A: Resistant starch: the effect on postprandial glycemia, hormonal response, and satiety. Am J Clin Nutr 60:544–551, 1994
Liljebert HGM, Åkerberg KE, Björck IME: Effect of the glycemic index and content of indigestible carbohydrates of cereal-based breakfast meals on glucose tolerance at lunch in healthy subjects. Am J Clin Nutr 69:647–655, 1999
Heijnen MLA, van Amelsvoort JMM, Weststrate JA: Interaction between physical structure and amylose: amylopectin ratio of food on postprandial glucose and insulin responses in healthy subjects. Eur J Clin Nutr 49:446–457, 1995
Achour L, Flourié B, Briet F, Franchisseur C, Bornet F, Champ M, Rambaud JC, Messing B: Metabolic effects of digestible and partially indigestible cornstarch: a study in the absorptive and postabsorptive periods in healthy humans. Am J Clin Nutr 66:1151–1159, 1997
Noakes M, Clifton PM, Nestel PJ, LeLeu R, McIntosh G: Effect of high-amylose starch and oat bran on metabolic variables and bowel function in subjects with hypertriglyceridemia. Am J Clin Nutr 64:944–951, 1996
Behall KM, Howe JC: Effect of long-term amylose vs amylopectin starch on metabolic variables in human subjects. Am J Clin Nutr 61:334–340, 1995
Luo J, Rizkalla W, Alamowitch C, Boussairi A, Blayo A, Barry JL, Lafitte A, Guyon F, Bornet F, Slama G: Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism. Am J Clin Nutr 63:939–945, 1996
Jenkins DJA, Vuksan V, Kendall CWC, Würsch P, Jeffcoat R, Waring S, Mehling CC, Vidgen E, Augustin LSA, Wong E: Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index. J Am Coll Nutr 17:609–661, 1998
Axelsen M, Arvidsson-Lenner R, Lönnroth P, Smith U: Breakfast glycaemic response in patients with type 2 diabetes: effects of bedtime dietary carbohydrates. Eur J Clin Nutr 53:706–710, 1999
Alles MS, Roos N, Boks J, Van de Lisdonk E, Zock P, Hautvast J: Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes. Am J Clin Nutr 69:64–69, 1999
Axelsen M, Lönnroth P, Arvidsson LR, Smith U: Suppression of the nocturnal free fatty acid levels by bedtime cornstarch in NIDDM. Euro J Clin Invest 27:157–163, 1997
Axelsen M, Lönnroth P, Arvidsson LR, Taskinen M, Smith U: Suppression of nocturnal free fatty acid concentrations by bedtime carbohydrate supplement in type 2 diabetes: effects on insulin sensitivity, lipids, and glycemic control. Am J Clin Nutr 71:1108–1114, 2000
Detlofson I, Kroon M, Åman J: Oral bedtime cornstarch supplementation reduces the risk of nocturnal hypoglycemia in young children with type 1 diabetes. Acta Paediatr 88:596–597, 1999
Kaufman FR, Halvorson M, Kaufman ND: A randomized blinded trial of uncooked cornstarch to diminish nocturnal hypoglycemia at diabetes camp. Diabetes Res Clin Pract 30:205–209, 1995
Axelsen M, Wesslau C, Lönnroth P, Arvidsson LR, Smith U: Bedtime uncooked cornstarch supplement prevents nocturnal hypoglycaemia in intensively treated type I diabetic subjects. J Intern Med 245:229–236, 1999
National Institutes of Environmental Health Sciences: 9th National Toxicology Report on Carcinogens. Washington, DC, DHHS, NIH, May 2000
Borzelleca JF, Verhagen H (Eds): Sucralose safety assessment. Food Chem Toxicol 38(Suppl. 2):S1–S129, 2000
Mezitis NH, Maggio CA, Koch P, Quuddoos A, Allison DB, Pi-Sunyer FX: Glycemic effect of a single high oral dose of the novel sweetener sucralose in patients with diabetes. Diabetes Care 19:1004–1005, 1996
Stargel WW, Mayhew DA, Comer P, Andress SE, Butchko HH: Neotame. In Alternative Sweeteners. Nabors LO, Ed. New York, Marcel Dekker, 2001, p. 129–145
Butchko HH, Stargel WW: Aspartame: scientific evaluation in the postmarketing period. Regul Toxicol Pharmacol. In press
Powers M: Sugar alternatives and fat replacers. In American Diabetes Association Guide to Medical Nutrition Therapy for Diabetes. Franz MJ, Bantle JP, Eds. Alexandria, VA, American Diabetes Association, 1999, p. 148–164
World Health Organization Expert Committee on Food Additives: Toxicological Evaluation of Certain Food Additives and Food Contaminants. Geneva, World Health Organization, 16:11–27, 18:12–14, 1981, 1983
U.S. Department of Agriculture, Center for Nutrition Policy and Promotion: Nutrient content of the US food supply, 1909–94. Home Economics Research Report No 53: US Government Printing Office, Washington, DC, 1997
U.S. Department of Agriculture, Agriculture Research Service: Food and Nutrient Intakes by Individuals in the United States by Sex and Age, 1994–96. Nationwide Food Surveys, Report No. 96–2, 1998
Randecker GA, Smiciklas-Wright H, McKenzie JM, Shannon BM, Mitchell DC, Becker DJ, Kieselhorst K: The dietary intake of children with IDDM. Diabetes Care 19:1370–1374, 1996
Gougeon R, Pencharz PB, Marliss EB: Effect of NIDDM on the kinetics of whole-body protein metabolism. Diabetes 43:318–328, 1994
Gougeon R, Pencharz PB, Sigal RJ: Effect of glycemic control on the kinetics of whole-body protein metabolism in obese subjects with non-insulin dependent diabetes mellitus during iso and hypoenergetic feeding. Am J Clin Nutr 65:861–870, 1997
Gougeon R, Marliss EB, Jones PJ, Pencharz PB, Morais JA: Effect of exogenous insulin on protein metabolism with differing non-protein energy intakes in type 2 diabetes. Int J Obes Relat Metab Disord 22:250–261, 1998
Gougeon R, Styhler K, Morais JA, Jones PJH, Marliss EB: Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes. Diabetes Care 23:1–8, 2000
Nair KS, Garrow JS, Ford C, Mahler RF, Halliday D: Effect of poor diabetic control and obesity on whole protein metabolism in man. Diabetologia 25:400–403, 1983
Felig P, Wahren J, Sherwin R, Palaiologos G: Amino acid and protein metabolism in diabetes mellitus. Arch Intern Med 137:507–513, 1977
Lariviere F, Chiasson J-L, Schiffrin A, Taveroff A, Hoffer LJ: Effects of dietary protein restriction on glucose and insulin metabolism in normal and diabetic humans. Metabolism 43:462–467, 1994
Brodsky IG, Robbins DC, Hiser E, Fuller SP, Fillyaw M, Devlin JT: Effects of low-protein diets on protein metabolism in insulin-dependent diabetes mellitus patients with early nephropathy. J Clin Endocrinol Metab 75:351–357, 1992
Brodsky IG, Devlin JT: Effects of dietary protein restriction on regional amino acid metabolism in insulin-dependent diabetes mellitus. Am J Physiol 270:E148–E157, 1996
Nyberg G. Norden G, Attman P-O, Aurell M, Uddebom G, Lenner RA, Isaksson B: Diabetic nephropathy: is dietary protein harmful? Diabetic Complications 1:37–40, 1987
Watts GF, Gregory L, Naoumova R, Kubal C, Shaw KM: Nutrient intake in insulin-dependent patients with diabetes with incipient nephropathy. Eur J Clin Nutr 42:697–702, 1988
Ekberg G, Sjofors G, Grefberg N, Larsson LO, Vaara I: Protein intake and glomerular hyperfiltration in insulin-treated diabetics without manifest nephropathy. Scand J Urol Nephrol 27:441–446, 1993
Toeller M, Buyken A: Protein intake: new evidence for its role in diabetic nephropathy. Nephrol Dial Transplant 13:1926–1927, 1998
Riley MD, Dwyer T: Microalbuminuria is positively associated with usual dietary saturated fat intake and negatively associated with usual dietary protein intake in people with insulin-dependent diabetes mellitus. Am J Clin Nutr 67:50–57, 1998
Jameel N, Pugh JA, Mitchell BD, Stern MP: Dietary protein intake is not correlated with clinical proteinuria in NIDDM. Diabetes Care 15:178–183, 1992
Skov AR, Toubro S, Bülow J, Krabbe K, Parving H-H, Astrup A: Changes in renal function during weight loss induced by high vs low-protein low-fat diets in overweight subjects. Int J Obes Relat Metab Disord 23:1170–1177, 1999
Toeller M, Buyken A, Heitkamp G, Bramswig S, Mann J, Milne R, Gries FA, Keen H, the EURODIAB IDDM Complications Study: Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study. Diabetologia 40:1219–1226, 1997
Westphal SA, Gannon MC, Nuttall FQ: Metabolic response to glucose ingested with various amounts of protein. Am J Clin Nutr 52:267–272, 1990
Nuttall FQ, Mooradian AD, Gannon MC, Billington CJ, Krezowski PA: Effect of protein ingestion on the glucose and insulin response to a standardized oral glucose load. Diabetes Care 7:465–470, 1984
Nordt TK, Besenthal I, Eggstein M, Jakober B: Influence of breakfasts with different nutrient contents on glucose, C peptide, insulin, glucagon, triglycerides, and GIP in non-insulin-dependent diabetics. Am J Clin Nutr 53:155–160, 1991
Gannon MC, Nuttall JA, Damberg G, Gupta V, Nuttall FQ: Effect of protein ingestion on the glucose appearance rate in people with type 2 diabetes. J Clin Endocrinol Metab 86:1040–1047, 2001
Gannon MC, Nuttall FQ: Protein and diabetes. In American Diabetes Association Guide to Medical Nutrition Therapy for Diabetes. Franz MJ, Bantle JP, Eds. American Diabetes Association, Alexandria, VA, 1999, p. 107–125
Peters AL, Davidson MB: Protein and fat effects on glucose responses and insulin requirements in subjects with insulin-dependent diabetes mellitus. Am J Clin Nutr 58:555–560, 1993
Gray RO, Butler PC, Beers TR, Kryshak EJ, Rizza RA: Comparison of the ability of bread versus bread plus meat to treat and prevent subsequent hypoglycemia in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 81:1508–1511, 1996
Larosa JC, Fry AG, Muesing R, Rosing DR: Effects of high-protein, low-carbohydrate dieting on plasma lipoproteins and body weight. J Am Diet Assoc 77:264–270, 1980
Kennedy ET, Bowman SA, Spence JT, Freedman M, King J: Popular diets: correlation to health, nutrition, and obesity. J Am Diet Assoc 101:411–420, 2001
Westerterp KR, Wilson SAJ, Rolland V: Diet induced thermogenesis measured over 24 h in a respiration chamber: effect of diet composition. Int J Obes Relat Metab Disord 23:287–292, 1999
Skov AR, Toubro S, Ronn B, Holm L, Astrup A: Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J Obes Relat Metab Disord 23:528–536, 1999
Hill AJ, Blundell JE: Macronutrients and satiety: the effects of high-protein or high-carbohydrate meal on subjective motivation to eat and food preferences. Nutrition and Behavior 3:133–144, 1986
Barkeling B, Rossner S, Bjorvell H: Effects of a high-protein meal (meat) and a high-carbohydrate meal (vegetarian) on satiety measured by automated computerized monitoring of subsequent food intake, motivation to eat and food preferences. Int J Obes Relat Metab Disord 14:743–751, 1990
Stubbs RJ, van Wyk MCW, Johnstone AM, Habron CG: Breakfasts high in protein, fat or carbohydrate: effect on within day appetite and energy intake. Eur J Clin Nutr 50:409–417, 1996
Rolls BJ, Hetherington M, Burley VJ: The specificity of satiety: the influence of food of different macronutrient content on the development of satiety. Physiol Behav 43:145–153, 1988
American Diabetes Association: Management of dyslipidemia in adults with diabetes (Position Statement). Diabetes Care 24(Suppl. 1):S58–S61, 2001
Hegsted DM, Ausman LM, Johnson JA, Dallal GE: Dietary fat and serum lipids: an evaluation of the experimental data. [Published erratum appears in Am J Clin Nutr 58:245, 1993]. Am J Clin Nutr 57:875–883, 1993
Schwab US, Ausman LM, Vogel S, Zhengling L, Lammi-Keefe CJ, Goldin BR, Ordovas JM, Schaefer EJ, Lichtenstein AH: Dietary cholesterol increases the susceptibility of low density lipoprotein to oxidative modification. Atherosclerosis 149:83–90, 2000
Hu FB, Stampfer MJ, Rjimm EB, Manson JE, Ascherio A, Colditz GA, Rosner BA, Spiegelman D, Speizer FE, Sacks FM, Hennekens CH, Willett WC: A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA 281:1387–1394, 1999
Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda S, Kris-Etherton PM: Effects of the National Cholesterol Education Program’s Step I and Step II dietary intervention programs of cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 69:632–646, 1999
Stone DB, Connor WE: The prolonged effects of a low cholesterol, high carbohydrate diet upon the serum lipids in patients with diabetes. Diabetes 12:127–132, 1963
Hjolllund E, Pedersen O, Richelsen B, Beck-Nielsen H, Sorensen NS: Increased insulin binding to adipocytes and monocytes and increased insulin sensitivity of glucose transport and metabolism in adipocytes from non-insulin-dependent diabetics after a low fat/high starch/high fiber diet. Metabolism 32:1067–1074, 1983
Simpson RW, Mann JI, Eaton J, Moore RA, Carter R, Hockaday TDR: Improved glucose control in maturity-onset diabetes treated with high-carbohydrate-modified fat diet. BMJ 1:1753–1756, 1979
Abbott WGH, Boyce VL, Grundy SM, Howard BV: Effects of replacing saturated fat with complex carbohydrate in diets of subjects with NIDDM. Diabetes Care 12:102–107, 1989
Brunzell JD, Lerner RL, Hazzard WR, Porte D, Bierman EL: Improved glucose tolerance with high carbohydrate feeding in mild diabetes. N Engl J Med 284:521–524, 1971
Brunzell JD, Lerner RL, Porte D, Bierman EL: Effect of a fat free, high carbohydrate diet on diabetic subjects with fasting hyperglycemia. Diabetes 23:138–142, 1974
Hales CN, Randle PJ: Effects of low-carbohydrate diet and diabetes mellitus on plasma concentrations of glucose, non-esterified fatty acid, and insulin during oral glucose tolerance tests. Lancet i:790–794, 1963
Kolterman OG, Greenfield M, Reaven GM, Saekow M, Olefsky JM: Effect of a high carbohydrate diet on insulin binding to adipocytes and on insulin action in vivo in man. Diabetes 28:731–736, 1979
Segal-Isaacson CJ, Carello E, Wylie-Rosett J: Dietary fats and diabetes mellitus: Is there a food fat? Current Diabetes Reports 1:161–169, 2001
Walker KZ, O’Dea K, Johnson L, Sinclair AJ, Piers LS, Nicholson GC, Muir JG: Body fat distribution and non-insulin-dependent diabetes: comparison of a fiber-rich, high-carbohydrate, low-fat (23%) and a 35% fat diet high in monounsaturated fat. Am J Clin Nutr 63:254–260, 1996
Parillo M, Rivellese AA, Ciardullo AV, Capaldo B, Giacco A, Genovese S, Ricardi G: A high-monounsaturated fat/low carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent patients with diabetes. Metabolism 41:1373–1378, 1992
Rasmussen OW, Thomsen C, Hanson KW, Vesterlund M, Winther E, Hermansen K: Effects on blood pressure, glucose, and lipid levels of a high-monounsaturated fat diet compared with a high-carbohydrate diet in non-insulin-dependent diabetic (NIDDM) subjects. Diabetes Care 16:1565–1571, 1993
Campbell LV, Marmot PE, Dyer JA, Borkman M, Storlien LH: The high-monounsaturated fat diet as a practical alternative for NIDDM. Diabetes Care 17:177–182, 1994
Lichtenstein AH, Ausman LM, Carrasco W, Jenner JL, Ordovas JM, Schaefer EJ: Short-term consumption of a low fat diet beneficially affects plasma lipid concentrations only when accompanied by weight loss. Arterioscler Thromb Vasc Biol 14:1751–1760, 1994
Heine RJ, Mulder C, Popp-Snijders C, van der Meer J, van der Meer EA: Linoleic-acid-enriched diet: long-term effects on serum lipoprotein and apolipoprotein concentrations and insulin sensitivity in noninsulin-dependent diabetic subjects. Am J Clin Nutr 49:448–456, 1989
Madigan C, Ryan M, Owens D, Collins P, Tomkin GH: Dietary unsaturated fatty acids in type 2 diabetes. Diabetes Care 23:1472–1477, 2000
Phillipson BE, Rothrock DW, Connor WE, Harris WS, Illingworth DR: Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 312:1210–1216, 1985
Harris WS, Connor WE, Illingworth DR, Rothrock DW, Foster DM: Effects of fish oil on VLDL triglyceride kinetics in humans. J Lipid Res 31:1549–1558, 1990
Sirtori CR, Paoletti R, Mancini M, Crepaldi G, Manzato E, Rivellese A, Pamparana F, Stragliotto E: N-3 fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance: Italian Fish Oil Multicenter Study. Am J Clin Nutr 65:1874–1881, 1997
Friedberg CE, Janssen MJEM, Heine RJ, Grobbee DE: Fish oil and glycemic control in diabetes: a meta-analysis. Diabetes Care 21:494–500, 1998
Montori VM, Farmer A, Wollan PC, Dinneen SF: Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care 23:1407–1415, 2000
Glauber H, Wallace P, Griver K, Brechtel G: Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann Intern Med 108:663–668, 1988
Westerveld HT, deGraaf JC, van Breugel HH, Akkerman JWN, Sixma JJ, Erkelens DW, Banga JD: Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein (a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM. Diabetes Care 16:683–688, 1993
Toft I, Bønaa KH, Ingebretsen OC, Nordøy A, Jenssen T: Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. Ann Intern Med 123:911–918, 1995
Patti L, Maffettone A, Iovine C, Marino LD, Annuzzi G, Riccardi G, Rivellese AA: Long-term effects of fish oil on lipoprotein subfractions and low density lipoprotein size in non-insulin-dependent patients with diabetes with hypertriglyceridemia. Atherosclerosis 146:361–367, 1999
Daviglus ML, Stamler J, Orencia AJ, Dyer AR, Liu K, Greenland P, Walsh MK, Morris D, Shekelle RB: Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 336: 1046–1053, 1997
Albert CM, Hennekens CH, O’Donnell CJ, Ajani UA, Carey VJ, Willet WC: Fish consumption and risk of sudden cardiac death. JAMA 279:65–66, 1998
Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetman R, Elwood PC, Deadman NM: Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 30:2(8666):757–761, 1989
de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N: Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final of the Lyon Diet Heart Study. Circulation 99:733–735, 1999
Mori TA, Beilin LJ, Burke V, Morris J, Ritchie J: Interactions between dietary fat, fish, and fish oils and their effect on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 17:279–286, 1997
Allison DB, Egan DK, Barraj LM, Caughman C, Infante M, Heimbach JT: Estimated intakes of trans fatty and other fatty acids in the US population. J Am Diet Assoc 99:166–174, 1999
Lichtenstein AH, Ausman LM, Jalbert SM, Schaefer EJ: Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. [Published erratum appears in N Engl J Med 341:856, 1999.] N Engl J Med 340:1933–1940, 1999
Judd JT, Clevidence BA, Muesing RA, Wittes J, Sunkin ME, Podczasy JJ: Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women. Am J Clin Nutr 59:861–868, 1994
Ascherio A, Katan MB, Zock PL, Stampfer MJ, Willett WC: Trans fatty acids and coronary heart disease. N Engl J Med 340:1994–1998, 1999
Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E: Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 333:1308–1312, 1995
Weststrate JA, Meijer GW: Plant sterol-enriched margarines and reduction of plasma total- and LDL cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 52:334–343, 1998
Hendriks HFJ, Weststrate JA, van Vliet T, Meijer GW: Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 53:319–327, 1999
Hallikainen MA, Uusitupa MIJ: Effects of two low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects. Am J Clin Nutr 69:403–410, 1999
Blair SN, Capuzzi DM, Gottlieb SO, Nguyen T, Morgan JM, Cater NB: Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am J Cardiol 86:46–52, 2000
Purnell JQ, Brunzell JD: Food fats and dyslipidemia. In American Diabetes Association Guide to Medical Nutrition Therapy for Diabetes. Franz MJ, Bantle JP, Eds. Alexandria, VA, American Diabetes Association, 1999, p. 126–147
Carmichael HE, Swinburn BA, Wilson MR: Lower fat intake as a predictor of initial and sustained weight loss in obese subjects consuming an otherwise ad libitum diet. J Am Diet Assoc 98:35–39, 1998
Larson DE, Ferraro RT, Robertson DS, Ravussin E: Energy metabolism in weight-stable postobese individuals. Am J Clin Nutr 62:735–739, 1995
Lissner L, Levitsky DA, Strupp BJ, Kalkwarf HJ, Roe DA: Dietary fat and the regulation of energy intake in human subjects. Am J Clin Nutr 46:886–892, 1987
Kendall A, Levitsky DA, Strupp BJ, Lissner L: Weight loss on a low-fat diet: consequence of the imprecision of the control of food intake in humans. Am J Clin Nutr 53:1124–1129, 1991
Schaefer EJ, Lichtenstein AH, Lamon-Fava S, McNamara JR, Schaefer MM, Rasmussen H, Ordovas JM: Body weight and low-density lipoprotein cholesterol changes after consumption of a low-fat ad libitum diet. JAMA 274:1450–1455, 1995
Doucet E, Alméras N, White MD, Després J-P, Bouchard C, Tremblay A: Dietary fat composition and human adiposity. Eur J Clin Nutr 52:2–6, 1998
Knopp RJ, Walden CE, Retzlaff BM, McCann BS, Dowdy AA, Albers JJ, Gey GO, Cooper MN: Long-term cholesterol-lowering effects of four fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men: the Dietary Alternatives Study. JAMA 278:1509–1515, 1997
Stamler J, Dolecek TA: Relation of food and nutrient intakes to body mass in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr 65:366S–373S, 1997
Tillotson JL, Grandits GA, Bartsch GE, Stamler J: Relation of dietary carbohydrates to blood lipids in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr 65:314S–326S, 1997
Sheppard L, Kristal AR, Kushi LH: Weight loss in women participating in a randomized trial of low-fat diets. Am J Clin Nutr 54:821–828, 1991
Westerterp KR, Verboeket-van de Venne WP, Westerterp-Plantenga MS, Velthuis-te Wierik EJ, de Graaf C, Weststrate JA: Dietary fat and body fat: an intervention study. Int J Obes Relat Metab Disord 20:1022–1026, 1996
Prewitt TE, Schmeisser D, Bowen PE, Aye P, Dolacek TA, Langenberg P, Cole T, Brace L: Changes in body weight, body composition, and energy intake in women fed high- and low-fat diets. Am J Clin Nutr 54:304–310, 1991
Blankenhorn DH, Azen SP, Kramsch DM, Mack WJ, Cashin-Hemphill L, Hodis HN, DeBoer LW, Mahrer PR, Masteller MJ, Vailas LI: Coronary angiographic changes with lovastatin therapy: the Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med 119:969–976, 1993
Turley ML, Skeaff CM, Mann JI, Cox B: The effect of a low-fat, high-carbohydrate diet on serum high density lipoprotein cholesterol and triglyceride. Eur J Clin Nutr 52:728–732, 1998
Watts GF, Lewis B, Brunt JN, Lewis ES, Coltart OJ, Smith LD, Mann JI, Swan AV: Effects on coronary artery disease of lipid-lowering diet or diet plus cholestyramine in the St. Thomas’ Atherosclerosis Regression Study (STARS). Lancet 339:563–569, 1992
Purnell JQ, Brunzell JD: The central role of dietary fat, not carbohydrate, in the insulin resistance syndrome. Curr Opin Lipidol 8:17–22, 1997
Reaven GM: Do high carbohydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against. Curr Opin Lipidol 8:23–27, 1997
Shah M, Garg A: High-fat and high-carbohydrate diets and energy balance. Diabetes Care 19:1142–1152, 1996
Pasqale R, Wing R, Butler B, Mullen M, Bononi P: Effects of a behavioral weight loss program stressing caloric restriction vs calorie plus fat restriction in obese individuals with NIDDM or a family history of diabetes. Diabetes Care 18:1241–1248, 1995
Astrup A, Ryan L, Grunwald GK, Storgaard M, Saris W, Melanson E, Hill JO: The role of dietary fat in body fatness: evidence from a preliminary meta-analysis of ad libitum low-fat dietary intervention study. Br J Nutr 83(Suppl. 1):S25−S32, 2000
Toubro S, Astrup A: Randomised comparison of diet for maintaining obese subjects’ weight after major weight loss: ad lib, low fat, high carbohydrate diet vs fixed energy intake. BMJ 314:29–34, 1997
Heilbronn L, Noakes M, Clifton P: Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes. Diabetes Care 22:889–895, 1999
Walker K, O’Dea K, Nicholson G, Muir J: Dietary composition, body weight, and NIDDM. Diabetes Care 18:401–403, 1995
Storm H, Thomsen C, Pedersen E, Rasmussen O, Christiansen C, Hermansen K: Comparison of a carbohydrate-rich diet and diets rich in stearic or palmitic acid in NIDDM patients. Diabetes Care 20:1807–1813, 1997
Mayer-Davis EJ, Levin S, Marshall JA: Heterogeneity in associations between macronutrient intake and lipoprotein profile in individuals with type 2 diabetes. Diabetes Care 22:1632–1639, 1999
Kelly SM, Shorthouse M, Cotterell JC, Riordan AM, Lee AJ, Thurnham DI, Hanka R, Hunter JO: A 3-month, double-blind, controlled trial of feeding with sucrose polyester in human volunteers. Br J Nutr 80:41–49, 1998
Sandler RS, Zorich NL, Filloon TG, Wiseman HB, Lietz DJ, Brock MH, Royer MG, Miday RK: Gastrointestinal symptoms in 3181 volunteers ingesting snack food containing olestra or triglycerides. Ann Intern Med 130:253–261, 1999
Warshaw H, Franz M, Powers MA, Wheeler M: Fat replacers: their use in food and role in diabetes medical nutrition therapy (Technical Review). Diabetes Care 19:1294–1301, 1996
Slama G, Rossi F, Bellisle F, Casassus P, Fiquet P, Chappuis AS, Desplanque N, Laffitte A: Low-fat (41%) butter consumption decreases total energy and lipid intake in patients with diabetes under acute conditions. Appetite 25:119–126, 1995
Rodriguez LM, Castellanos VH: Use of low-fat food by people with diabetes decreases fat, saturated fat, and cholesterol intakes. J Am Diet Assoc 100:531–536, 2000
DeGraaf C, Hulshof T, Weststrate JA, Hautvast GAJ: Nonabsorbable fat (sucrose polyester) and the regulation of energy intake and body weight. Am J Physiol 270:R1386–R1393, 1996
Cotton JR, Weststrate JA, Blundell JE: Replacement of dietary fat with sucrose polyester: effects on energy intake and appetite control in nonobese males. Am J Clin Nutr 63:891–896, 1996
Cowie CC, Harris MI: Physical and metabolic characteristics of persons with diabetes. In Diabetes in America. 2nd ed. National Diabetes Data Group, Eds. Bethesda, MD, NIH, NIDDK, 1995, p. 117–164 (NIH publ. no. 95–1468)
Campbell PJ, Gerich JE: Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for adverse effect of obesity. J Clin Endocrinol Metab 70:1114–1118, 1990
Olefsky JM, Kolterman OG, Scarlett JA: Insulin action and resistance in obesity and non insulin-dependent diabetes mellitus. Am J Physiol 243:E15–E30, 1982
Albu J, Konnaaarides C, Pi-Sunyer FX: Weight control: metabolic and cardiovascular effects. Diabetes Rev 3:335–347, 1995
Hughes TA, Gwynne JT, Switzer BR, Herbst C, White G: Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus. Am J Med 77:7–17, 1984
Henry RR, Wiest-Kent A, Scheaffer L, Kolterman OG, Olefsky JM: Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects. Diabetes 35:155–164, 1986
Amatruda JM, Richeson JF, Welle SL, Brodows RG, Lockwood DH: The safety and efficacy of a controlled low energy (very-low-calorie) diet in the treatment of non-insulin dependent diabetes and obesity. Arch Intern Med 148:873–877, 1988
Sarlio-Lähteenkorva S, Rissanen A, Kapprio J: A descriptive study of weight-loss maintenance: 6 and 15 year follow-up of initially overweight adults. Int J Obes Relat Metab Disord 24:116–125, 2000
McGuire MT, Wing RR, Hill JO: The prevalence of weight loss maintenance among American adults. Int J Obes Relat Metab Disord 23:1314–1319, 1999
Hanefeld M, Fischer S, Schmechel H, Rothe G, Schulze J, Dude H, Schwanebeck U, Julius U: Diabetes Intervention Study: multi-intervention trial in newly diagnosed NIDDM. Diabetes Care 14:308–317, 1991
Laitinen JH, Ahola IE, Sarkkinen ES, Winberg RL, Harmaakorpi-Ivonen PA, Uusitupa MI: Impact of intensified dietary therapy on energy and nutrient intakes and fatty acid composition of serum lipids with recently diagnosed non-insulin dependent diabetes mellitus. J Am Diet Assoc 93:276–283, 1993
Hadden DR, Blair ALT, Wilson EZ, Boyle DM, Atkinson B, Kennedy AL, Buchanan KD, Merrett JD, Montgomery DAD, Weaver JA: Natural history of diabetes presenting at age 40–69 years: a prospective study of the influence of intensive dietary therapy. QJM 59:579–598, 1986
Porte D Jr, Seeley RJ, Woods SC, Baskin DG, Figlewicz DP, Schwartz MW: Obesity, diabetes and the central nervous system. Diabetologia 41:863–881, 1998
Stunkard AJ, Sorensen TIA, Hanis C, Teasdale TW, Chakraborty R, Schull WJ, Schulsinger F: An adoption study of human obesity. N Engl J Med 314:193–198, 1986
Bouchard C, Tremblay A, Despres JP, Nadeau A, Lupien PJ, Theriault G, Dussault J, Moorjani S, Pinault S, Fournier G: The response to long-term overfeeding in identical twins. N Engl J Med 322:1477–1482, 1990
Stunkard AJ, Harris JR, Pedersen NL, McClearn GE: The body-mass index of twins who have been reared apart. N Engl J Med 322:1483–1487, 1990
Klem ML, Wing RR, McGuire MT, Seagle HM, Hill JO: A descriptive study of individuals successful at long-term maintenance of substantial weight loss. Am J Clin Nutr 66:239–246, 1997
The Diabetes Prevention Program Research Group: The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care 22:623–634, 1999
DPP. www.preventdiabetes.com. Accessed October 2001
Wing RR, Venditti E, Jakicic JM, Polley BA, Lang W: Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Care 21:350–359, 1998
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Aunola S, Cepaitis Z, Moltchanov V, Hakumaki M, Mannelin M, Martikkala V, Sundvall J: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350, 2001
Tucker LA, Kano MJ: Dietary fat and body fat: a multivariate study of 205 adult females. Am J Clin Nutr 56:612–622, 1992
Westsrate JA: Fat and obesity. Int J Obes Relat Metab Disord 19 (Suppl.):S38–S43, 1995
Kasim SE, Martino S, Kim PN, Khilnani S, Boomer A, Depper J, Reading BA, Heilbrum LK: Dietary and anthropometric determinates of plasma lipoproteins during a long-term low fat diet in healthy women. Am J Clin Nutr 57:146–153, 1993
Sheppard L, Kristal AR, Kushi LH: Weight loss in women participating in a randomized trial of low fat diets. Am J Clin Nutr 54:821–828, 1993
Pavlou KN, Krey S, Steffee WP: Exercise as an adjunct to weight loss and maintenance in moderately obese subjects. Am J Clin Nutr 49:1115–1123, 1989
Maggio CA, Pi-Sunyer FX: The prevention and treatment of obesity: application to type 2 diabetes (Technical Review). Diabetes Care 20:1744–1766, 1997
Brown S, Upchurch S, Anding T, Winter M, Ramirez G: Promoting weight loss in type 2 diabetes. Diabetes Care 19:613–624, 1996
Foreyt JP, Goodrick GK: Evidence for success of behavior modification in weight loss and control. Ann Intern Med 119:698–701, 1993
Technology Assessment Conference Panel: Methods for voluntary weight loss and control: Technology Assessment Conference statement. Ann Intern Med 119:764–770, 1993
Wadden TA: Treatment of obesity by moderate and severe caloric restriction: results of clinical trials. Ann Intern Med 119:688–693, 1993
Ditschuneit HH, Flechtner-Mors M, Johnson TD, Adler G: Metabolic and weight-loss effects at a long-term dietary intervention in obese patients. Am J Clin Nutr 69:198–204, 1999
Rothacker DQ: Five year self-management of weight using meal replacements: comparison with matched control in rural Wisconsin. Nutr 16:344–348, 2000
Ashley JM, St. Jeor ST, Schrage JP, Perumean-Chaney SE, Gilbertson MN, McCall NL, Bovee V: Weight control in the physician’s office. Arch Intern Med 161:1599–1604, 2001
Rothacker DQ, Staniszewki BA, Ellis PK: Liquid meal replacement vs traditional food: a potential model for women who cannot maintain eating habit change. J Am Diet Assoc 101:345–347, 2001
Metz JA, Stern JS, Kris-Etherton P, Reusser ME, Morris CD, Hatton D, Oparil S, Haynes RB, Renick LM, Pi-Sunyer FX, Clark S, Chester L, McMahon M, Snyder GW, McCarron DA: A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients. Arch Intern Med 160:2150–2158, 2000
Wing RR, Marcus MD, Salata R, Epstein LH, Miaskiewicz S, Blair EE: Effects of a very low calorie diet on long-term glycemic control in obese type 2 diabetic subjects. Arch Intern Med 151:1334–1340, 1991
Henry RR, Gumbiner B: Benefits and limitations of very low calorie diet therapy in obese NIDDM. Diabetes Care 14:802–823, 1991
Wing RR: Use of very-low-calorie diets in the treatment of obese persons with non-insulin dependent diabetes mellitus. J Am Diet Assoc 95:569–572, 1995
Weintraub M: Long-term weight control: the National Heart, Lung, and Blood Institute Multimodal Intervention Study. Clin Pharmacol Ther 51:586–646, 1992
Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV: Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337:581–588, 1997
Redmon JB, Raatz SK, Kwong CA, Swanson JE, Thomas W, Bantle JP: Pharmacologic induction of weight loss to treat type 2 diabetes. Diabetes Care 22:896–903, 1999
Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE, Weinstein SP, the Sibutramine/Diabetes Clinical Study Group: Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus. Diabetes Obes Metab 2:175–187, 2000
Hollander PA, Elbein SC, Hirsch IB, Kelley C, McGill J, Taylor T, Weiss SR, Crockett SE, Kaplan RA, Comstock J, Lucas CP, Lodewick PA, Canovatchel W, Chung J, Hauptman J: Role of orlistat in the treatment of obese patients with type 2 diabetes: a randomized double-blind study. Diabetes Care 21:1288–1294, 1998
Lindgarde F, Orlistat Swedish Multimorbidity Study Group: The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study. J Intern Med 248:245–254, 2000
Nightengale ML, Sarr MG, Kelly KA, Jensen MD, Zinsmeister AR, Palumbo PJ: Prospective evaluation of vertical banded gastroplasty as the primary operation for morbid obesity. Mayo Clin Proc 66:773–782, 1991
Pories WJ, MacDonald KG, Flickinger EG, Dohm GL, Sinha MK, Barakat HA, May HJ, Khazanie P, Swanson MS, Morgan E, Leggett-Frazier N, Long SD, Brown BM, O’Brien K, Caro JF: Is type II diabetes mellitus (NIDDM) a surgical disease? Ann Surg 215:633–642, 1992
Dixon JB, O’Brien PE: Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care In press
Consensus Development Conference Panel: Gastrointestinal surgery for severe obesity. Ann Intern Med 115:956–961, 1991
Sugerman HJ, Brewer WH, Shiffman ML, Brolin RE, Fobi MAL, Linner JH, MacDonald KG, MacGregor AM, Martin LF, Oram-Smith JC, Popoola D, Schirmer BD, Vickers FF: A multicenter, placebo controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg 169:91–97, 1995
Institute of Medicine Food and Nutrition Board: Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC, National Academy Press, 2000
Institute of Medicine Food and Nutrition Board: Dietary Reference Intakes for Thiamine, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC, National Academy Press, 1998
Institute of Medicine Food and Nutrition Board: Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC, National Academy Press, 2001
Institute of Medicine Food and Nutrition Board: Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC, National Academy Press, 1997
Food and Nutrition Board: Recommended Dietary Allowances. 10th ed. Washington, DC, National Academy of Sciences, 1989
Food and Nutrition Board: Nutrition During Pregnancy. Part 1: Weight Gain. Part 2: Nutrient Suppl. Washington, DC, Institute of Medicine, National Academy of Sciences, 1990
Mooradian AD, Failla M, Hoogwerf B, Maryniuk M, Wylie-Rosett: Selected vitamins and minerals in diabetes. Diabetes Care 17:464–479, 1994
Mooradian AD: Micronutrients in diabetes mellitus. In Drugs, Diet and Disease 2:183–200, 1999
Klipstein-Grobusch K: Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr 69:261–266, 1999
Will JC, Ford ES, Bowman BA: Serum vitamin C concentrations and diabetes: findings from the Third National Health and Nutrition Examination Survey 1988–1994. Vit C in diabetes. NHANES III. Am J Clin Nutr 70:49–52, 1999
Mayer-Davis EJ, Bell KA, Reboussin BA, Rushing J, Marshall JA, Hamman RF: Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. Ophthalmology 105:2264–2270, 1998
Coudray C, Roussel AM, Mainard F, Arnaud J, Favier A: Lipid peroxidation level and antioxidant micronutrient status in a pre-aging population: correlation with chronic disease prevalence in a French epidemiological study. J Am Coll Nutr 16:584–591, 1997
Mayer-Davis EJ, Monaco JH, Marshall JA, Rushing J, Juhairi J: Vitamin C intake and cardiovascular disease risk factors in persons with non-insulin-dependent diabetes mellitus: from the Insulin Resistance Atherosclerosis Study and the San Luis Valley Diabetes Study. Prev Med 26:277–283, 1997
Sanchez-Lugo L, Mayer-Davis EJ, Howard G, Selby JV, Ayad MF, Rewers M, Haffner S: Insulin sensitivity and intake of vitamins E and C in African American, Hispanic, and non-Hispanic white men and women: the Insulin Resistance and Atherosclerosis Study (IRAS). Am J Clin Nutr 66:1224–1231, 1997
Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R: Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334:1145–1149, 1996
Knekt P, Jarvinen R, Reunanen A, Maatela J: Flavenoid intake and coronary mortality in Finland: a cohort study. BMJ 312:478–481, 1996
Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM: Dietary antioxidant vitamins and death from coronary in post-menopausal women. N Engl J Med 334:1156–1162, 1996
Losonczy KG, Harris TB, Havlik RS: Vitamin E and vitamin C supplement use and risk of all cause and coronary heart disease mortality in older persons: the Established Population for Epidemiologic Studies of the Elderly. Am J Clin Nutr 64:190–196, 1996
Gaziano JM, Manson JE, Branch LC, Colditz GA, Willett WC, Buring JE: A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol 5:255–260, 1995
Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A: Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 139:1180–1189, 1994
Rimm EB, Stampfer MJ, Ascherio A, GioVannucci E, Colditz GA, Willett WC: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328:1450–1456, 1993
Shoff SM, Mares-Pellman JA, Cruickshanks KJ, Klein R, Klein BE, Ritler LL: Glycosylated hemoglobin concentrations and vitamin E, vitamin C, and beta-carotene intake in diabetic and non-diabetic older adults. Am J Clin Nutr 58:412–416, 1993
Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC: Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328:1444–1449, 1993
Enstrom JE, Kanim LE, Klein MA: Vitamin C intake and mortality among a sample of the United States population. Epidemiology 3:194–202, 1992
Salonen JT, Nyyssonen K, Tuomainen TP, Maenpaa PH, Korpela H, Kaplan GA, Lynch J, Helmrich SP, Salonen R: Increased risk of non-insulin-dependent diabetes mellitus at low plasma vitamin E concentrations: a four year study in men. BMJ 311:1124–1127, 1995
Gey KF, Puska P: Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural pathology. Ann N Y Acad Sci 570:268–282, 1989
Christen WG, Gaziano JM, Hennekens CH: Design of Physicians’ Health Study II: a randomized trial of beta carotene, vitamins E and C and multivitamins, in prevention of cancer, cardiovascular disease and eye disease and review of results of completed trials. Ann Epidemiol 10:125–134, 2000
Ford ES, Will JC, Bowman BA, Narayan KM: Diabetes mellitus and serum carotenoids: findings from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 149:168–176, 1999
Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P: Vitamin E supplementation and cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:154–160, 2000
GISSI-Prevenzione Investigators: Dietary supplements with n-3 poly unsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevention Trial. Lancet 354:447–455, 1999
Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B, Williams JH Jr, Barnhart S, Cherniak MG, Brodkin CA, Hammar S: Risk factors for lung cancer and for intervention effects in CARET: the Beta Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 88:1550–1559, 1996
Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ: Randomized, controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study. Lancet 347:781–786, 1996
ATBC (Alpha-Tocopherol, Beta Carotene) Cancer Prevention Study Group: the effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330:1029–1035, 1994
Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GO, Yang CS, Zheng SF, Gail M, Li GY: Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combination, cancer incidence and disease-specific mortality in general population. J Natl Cancer Inst 85:1483–1492, 1993
Bursell S-E, Clermont AC, Aiello LP, Aiello LM, Schlossman DK, Feener EP, Laffel L, King GL: High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 22:1245–1251, 1999
Astley S, Langrish-Smith A, Southon S, Sampson M: Vitamin E supplementation and oxidative damage to DNA and plasma LDL in type 1 diabetes. Diabetes Care 22:1626–1631, 1999
Upritchard JE, Sutherland WHF, Mann JI: Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 23:733–738, 2000
Paolisso G, D’Amore A, Galzerano D, Balbi B, Giugliano D, Varricchio M, D’Onofrio F: Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type 2 patients with diabetes. Diabetes Care 16:1433–1437, 1993
Reaven PD, Herold DA, Barnett J, Edelman S: Effects of vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM. Diabetes Care 18:807–816, 1995
Koehler KM, Pareo-Tubbeh SL, Romero LJ, Baumgartner RN, Garry PJ: Folate nutrition and older adults: challenges and opportunities. J Am Diet Assoc 97:167–173, 1997
Pozzilli P, Visalli N, Signore A, Baroni MG, Buzzetti R, Cavallo MG, Boccuni ML, Fava D, Gragnoli C, Andreani D: Double-blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study). Diabetologia 38:848–852, 1995
Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E, Mesturino C, Fiori R, Lucentini L, Matteoli MC, Crino A, Corgbi S, Spera S, Teodonio C, Paci F, Amoretti R, Pisano L, Suraci C, Multari G, Sulli N, Cervoni M, De Mattia G, Faldetta MR, Boscherini B, Pozzilli P: A multi-centre, randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI). Diabetes Metab Res Rev 15:181–185, 1999
Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, Feng J: Beneficial effects of chromium for people with diabetes. Diabetes 46:1786–1791, 1997
Cheng N, Zhu X, Shi H, Wu W, Chi J, Cheng J, Anderson RA: Follow-up survey of people in China with type 2 diabetes mellitus consuming supplemental chromium. J Trace Elem Exp Med 12:55–60, 1999
Ravina A, Slezak L, Rubal A, Mirsky N: Clinical use of trace element chromium (III) in the treatment of diabetes mellitus. J Trace Elem Exp Med 8:183–190, 1995
Cefalu WT, Bell-Farrow AD, Stegner J, Wang ZQ, King T, Morgan, Terry JG: Effect of chromium picolinate on insulin sensitivity in vivo. J Trace Elem Exp Med 12:71–83, 1999
Jovanovic L, Gutierrez M, Peterson CM: Chromium supplementation for women with gestational diabetes mellitus. J Trace Elem Exp Med 12:91–97, 1999
Ravina A, Slezak L, Mirsky N, Bryden NP, Anderson RA: Reversal of corticosteroid-induced diabetes with supplemental chromium. Diabet Med 16:164–167, 1999
Sherman L, Glennon JA, Brech WJ, Klomberg GH, Gordon ES: Failure of trivalent chromium to improve hyperglycemia in diabetes mellitus. Metabolism 17:439–442, 1968
Abraham AS, Brooks BA, Eylat U: The effect of chromium supplementation on serum glucose and lipids in patients with non-insulin-dependent diabetes mellitus. Metab Clin Exp 41:768–771, 1992
Uusitupa M, Kumpulainen J, Voutilainen E, Sarlund H, Hersio K, Pyorala K, Koivistoinen P, Lehto J: The effect of chromium supplementation on glucose tolerance, insulin response and serum lipids in maturity onset diabetes. Duodecim 100:29–34, 1984
Uusitupa MI, Mykkanen L, Siitonen O, Laakso M, Sarlund H, Kolehmainen P, Rasanen T, Kumpulainen J, Pyörälä K: Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. Br J Nutr 68:209–216, 1992
Song MK, Rosenthal MJ, Naliboff BD, Phanumas L, Kang KW: Effects of bovine prostate powder on zinc, glucose, and insulin metabolism in old patients with non-insulin-dependent diabetes mellitus. Metabolism 47:39–43, 1998
Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, Jamal SA, Black DM, Cummings SR: Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86:32–38, 2001
Cohen N, Halberstam M, Schilmovich P, Chang CJ, Shamoon H, Rosetti L: Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin dependent diabetes mellitus. J Clin Invest 95:2501–2509, 1995
Goldfine A, Simonson D, Folli F, Patti ME, Kahn R: Metabolic effects of sodium metavanadate in humans with insulin-dependent and non-insulin dependent diabetes mellitus in vivo and in vitro studies. J Clin Endocrinol Metab 80:3311–3320, 1995
Verma S, Cam MC, McNeill JH: Nutritional factors which can favorably influence the glucose, insulin system: vanadium. J Am Coll Nutr 17:11–18, 1998
Boden G, Chen X, Ruiz J, vanRossum GD, Turco S: Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Metabolism 45:1130–1135, 1996
Vuksan V, Stavro MP, Sievenpiper JL, Beljan-Zdravkovic U, Leiter LA, Josse RG, Xu Z: Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. Diabetes Care 23:1221–1226, 2000
Vuksan V, Sievenpiper JL, Koo VY, Francis T, Beljan-Zdravkovic U, Yu Z, Vidgen E: American ginseng (Panax quinquefolius L) reduces postprandial glycemia in non-diabetic subjects and subjects with type 2 diabetes mellitus. Arch Intern Med 160:1009–1013, 2000
Subar AF, Krebs-Smith SM, Cook A, Kahle LL: Dietary sources of nutrients among US adults, 1989 to 1991. J Am Diet Assoc 98:537–547, 1998
Block G, Dresser CM, Hartman AM, Carroll MD: Nutrient sources in the American diet: quantitative data from the NHANES II survey. II. Macronutrients and fats. Am J Epidemiol 122:27–40, 1985
Braum-Baicker C: The health benefits of moderate alcohol consumption: a review of the literature. Drug Alcohol Depend 15:207–227, 1985
Rimm EB, Klatsky A, Grobbee Stumpfer MJ: Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effects due to beer, wine, or spirits? BMJ 312:731–736, 1996
Wannamethee SG, Shaper AG: Type of alcoholic drink and risk of major coronary heart disease events and all-cause mortality. Am J Public Health 89:685–690, 1999
Pownall HJ, Ballantyne CM, Kimball KT, Simpson SL, Yeshurum D, Grotto AM: Effect of moderate alcohol consumption on hypertriglyceridemia. Arch Intern Med 159:981–987, 1999
Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS: High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 322:95–99, 1990
Lange J, Arends J, Willms B: Alcohol-induced hypoglycemia in type 1 diabetes. Med Klin 86:551–554, 1991
Arky RA, Veverbrand E, Abramson EA: Irreversible hypoglycemia: a complication of alcohol and insulin. JAMA 206:575–578, 1968
Gin H, Morlat P, Ragnaut JM, Aubertin J: Short-term effect of red wine (consumed during the meals) on insulin requirement and glucose tolerance in diabetic patients. Diabetes Care 15:546–548, 1992
Koivisto VA, Tulokas S, Toivonen M, Haapa E, Pelkonen R: Alcohol with meal has no adverse effects on postprandial glucose homeostasis in patients with diabetes. Diabetes Care 16:1612–1614, 1993
Ben G, Gnidi L, Maran A, Gigante A, Duner E, Iori E, Tiengo A, Avogaro A: Effects of chronic alcohol intake on carbohydrate and lipid metabolism in subjects with type II (non-insulin-dependent) diabetes. Am J Med 90:70–76, 1991
Feingold KR, Siperstein MD: Normalization of fasting blood glucose levels in insulin-requiring diabetes: the role of ethanol abstention. Diabetes Care 6:186–188, 1983
Kerr D, Macdonald IA, Heller SR, Tattersall RB: Alcohol causes hypoglycaemic unawareness in healthy volunteers and patients with type I (insulin-dependent) diabetes. Diabetologia 33:216–221, 1990
Franz MJ: Alcohol and diabetes. In American Diabetes Association Medical Nutrition Therapy for Diabetes. Franz MJ, Bantle JP, Eds. Alexandria, VA, American Diabetes Association, 1999, p. 192–208
Walsh CH, O’Sullivan DJ: Effect of moderate alcohol intake on control of diabetes. Diabetes 23:440–442, 1974
McMonagle J, Felig P: Effects of ethanol ingestion on glucose tolerance and insulin secretion in normal and diabetic subjects. Metabolism 24:625–632, 1975
Avogaro A, Duner E, Marescotti C, Ferrara D, Del Prato S, Nosadini R, Tiengo A: Metabolic effects of moderate alcohol intake with meals in insulin-dependent diabetics controlled by artificial endocrine pancreas (AEP) and in normal subjects. Metabolism 32:463–469, 1983
Singh SP, Kumar Y, Snyder AK, Ellyin FE, Gilden JL: Effect of alcohol on glucose tolerance in normal and noninsulin-dependent diabetic subjects. Alcohol Clin Exp Res 12:727–730, 1988
Spraul M, Chantelau E, Schonbach A-M, Berger M: Glycemic effects of beer in IDDM patients: studies with constant insulin delivery. Diabetes Care 11:659–661, 1988
Menzel R, Mentel DC, Brunsteil U, Heinke P: Effect of moderate ethanol ingestion on overnight diabetes control and hormone secretion in type I patients with diabetes (Abstract). Diabetologia 34:A188, 1991
Christiansen C, Thomsen C, Rasmussen O, Glerup H, Berthelsen H, Hansen C, Orskov H, Hermansen K: Acute effects of graded alcohol intake on glucose, insulin, and free fatty acid levels in non-insulin-dependent diabetic subjects. Eur J Clin Nutr 47:648–652, 1993
Christiansen C, Thomsen C, Rasmussen O, Balle M, Hauerslev C, Hansen C, Hermansen K: Wine for type 2 patients with diabetes? Diabet Med 10:958–961, 1993
Ajani UA, Hennekens CH, Spelsberg A, Manson JE: Alcohol consumption and risk of type 2 diabetes mellitus among US male physicians. Arch Intern Med 160:1025–1030, 2000
Tsumura K, Hayashi T, Suematsu C, Endo G, Fujii S, Okada K: Daily alcohol consumption and the risk of type 2 diabetes in Japanese men: the Osaka Health Study. Diabetes Care 22:1432–1437, 1999
Wei M, Gibbon LW, Mitchell TL, Kampert JB, Blair SN: Alcohol intake and incidence of type 2 diabetes in men. Diabetes Care 23:18–22, 2000
Sacco RL, Elkind M, Boden-Albala B, Lin IF, Kargman DE, Hauser WA, Shea D, Paik MC: The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 281:53–60, 1999
Mayer EJ, Newman B, Quesenberry CP, Friedman GD, Selby JV: Alcohol consumption and insulin concentrations: role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation 88:2190–2197, 1993
Facchini F, Chen Y-D, Reaven GM: Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care 17:115–119, 1994
Bell RA, Mayer-Davis EJ, Martin MA, D’Agostino RB, Haffner SM: Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care 23:1630–1636, 2000
Valmadrid CT, Klein R, Moss SE, Klein BK, Cruickshanks KJ: Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus. JAMA 282:239–246, 1999
Solomon CG, Hu FB, Stampfer MJ, Colditz GA, Speizer FE, Rimm EB, Willett WC, Manson JE: Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation 102:494–499, 2000
Ajani UA, Gaziano M, Lotufo PA, Liu S, Hennekens CH, Buring JE, Manson JE: Alcohol consumption and risk of coronary heart disease by diabetes status. Circulation 102:500–505, 2000
Israelsson B: Role of alcohol, glucose intolerance and obesity in hypertriglyceridemia. Atherosclerosis 62:123–127, 1986
Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157:2413–2446, 1997
Tsuruta M, Adachi H, Hirai Y, Fujiura Y, Imaizumi T: Association between alcohol intake and development of hypertension in Japanese normotensive men: 12-year follow-up study. Am J Hypertens 13:482–487, 2000
Nanchahal K, Ashton WD, Wood DA: Alcohol consumption, metabolic cardiovascular risk factors and hypertension in women. Int J Epidemiol 29:57–64, 2000
Keil U, Liese A, Filipiak B, Swales JD, Grobbee DE: Alcohol, blood pressure and hypertension. Novartis Found Symp 216:125–151, 1998
Friedman GD, Selby JV, Quesenberry CP, Armstrong MA, Klatsky AL: Precursors of essential hypertension: body weight, alcohol and salt use, and parental history of hypertension. Prev Med 17:387–402, 1988
Working Group Report on Primary Prevention of Hypertension: National High Blood Pressure Education Program. U.S. Department of Health and Human Services, May 1993 (NIH publ. no. 93–2669)
The DCCT Research Group: Weight gain associated with intensive therapies in the Diabetes Control and Complications Trial. Diabetes Care 11:567–573, 1988
Wing RR, Klein R, Moss SE: Weight gain associated with improved glycemic control in population-based sample of type 1 diabetic subjects. Diabetes Care 13:1106–1109, 1990
Carlson MG, Campbell PJ: Intensive insulin therapy and weight gain in IDDM. Diabetes 42:1700–1707, 1993
Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD: Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure. JAMA 280:140–146, 1998
Williams KV, Erbey JR, Becker D, Orchard TJ: Improved glycemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes. Diabetes Care 22:1084–1091, 1999
The DCCT Research Group: Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 90:450–459, 1990
Slama G, Traynard, P-Y, Desplanque N, Pudar H, Dhunputh I, Letanoux M, Bornet FRJ, Tchobroutsky G: The search for an optimized treatment of hypoglycemia: carbohydrates in tablets, solution, or gel for the correction of insulin reactions. Arch Intern Med 150:589–593, 1990
The American Diabetes Association: Diabetes mellitus and exercise (Position Statement). Diabetes Care 25(Suppl. 1):S64–S68, 2002
Wasserman DH, Zinman B: Exercise in individuals with IDDM (Technical Review). Diabetes Care 17:924–937, 1994
Rabasa-Lhoret R, Bourque J, Ducros F, Chiasson J-L: Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (Ultralente-Lispro). Diabetes Care 24:625–630, 2001
Lamb DR, Brodowicz GR: Optimal use of fluids of varying formulation to minimize exercised-induced disturbances in homeostasis. Sport Med 3:247–274, 1986
Coyle EF, Hagberg JM, Hurley BS, Martin WH, Ehsani AA, Holloszy JO: Carbohydrate feeding during prolonged strenuous exercise can delay fatigue. J Appl Physiol 55:230–235, 1983
Wahren J, Felig P, Hagenfeldt PL: Physical exercise and fuel homeostasis in diabetes mellitus. Diabetologia 14:213–222, 1978
Ivy JL, Katz SL, Cutler CL, Sherman WM, Coyle EF: Muscle glycogen synthesis after exercise: effects of time of carbohydrate ingestion. J Appl Physiol 64:1480–1485, 1988
Wing RR, Blair EH, Bononi P, Marcus MD, Watanabe R, Bergman RN: Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care 17:30–36, 1994
Kelley DE, Wing R, Buonocore C, Sturis J, Polonsky K, Fitzsimmons M: Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77:1287–1293, 1993
Markovic TP, Jenkins AB, Campbell LV, Furler SM, Kraegen EW, Chisholm DJ: The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM. Diabetes Care 21:687–694, 1998
Albright A, Franz M, Hornsby G, Kriska A, Marrero D, Ullrich I, Verity LS: American College of Sports Medicine position stand: exercise and type 2 diabetes. Med Sci Sports Exerc 32:1345–1350, 2000
Barnard RJ, Jung T, Inkeles S: Diet and exercise in treatment of NIDDM: the need for early emphasis. Diabetes Care 17:1469–1472, 1994
Wing RR, Koeske R, Epstein LH, Nowalk MP, Gooding W, Becker D: Long-term effects of modest weight loss in type II patients with diabetes. Arch Intern Med 147:1749–1753, 1987
Watts NB, Spanheimer RG, DiGirolamo M, Gebhart SS, Musey VC, Siddiq K, Phillips LS: Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus. Arch Intern Med 150:803–806, 1990
Markovic TP, Campbell LV, Balasubramanian S, Jenkins AB, Fleury AC, Simons LA, Chisholm DJ: Beneficial effect on average lipid levels from energy restriction and fat loss in obese individuals with or without type 2 diabetes. Diabetes Care 21:695–700, 1998
Pi-Sunyer FW: Weight loss and non-insulin dependent diabetes mellitus. Am J Clin Nutr 63 (Suppl.):426S−429S, 1996
Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T: Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care 23:1499–1504, 2000
Schneider SH, Khachadurian AK, Amorosa LF, Lemow L, Ruderman NB: Ten-year experience with exercise-based outpatient life-style modification program in the treatment of diabetes mellitus. Diabetes Care 15:1800–1810, 1992
Yamanouchi K, Shinozaki T, Chikada K, Nishikawa T, Ito K, Shimizu S, Ozawa N, Suzuki Y, Maeno H, Kato K, Oshida Y, Sato Y: Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity. Diabetes Care 18:775–778, 1995
Mayer-Davis EJ, D’Agostino R Jr, Karter AJ, Haffner SM, Rewers MJ, Saad M, Bergmans RN: Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance and Atherosclerosis Study (IRAS). JAMA 279:669–674, 1998
Hu FB, Stampfer MJ, Solomon C, Liu S, Colditz GA, Speizer FE, Willett WC, Manson JE: Physical activity and risk for cardiovascular events in diabetic women. Ann Intern Med 134:96–105, 2001
Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN: Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med 132:605–611, 2000
Arnold L, Mann J, Ball M: Metabolic effects of alterations in meal frequency in type 2 diabetes. Diabetes Care 20:1651–1654, 1997
Beebe CA, Van Cauter E, Shapiro T, Tillel H, Lyons R, Rubenstein A, Polonsky K: Effect of temporal distribution of calories on diurnal patterns of glucose levels and insulin secretion in NIDDM. Diabetes Care 13:748–755, 1990
Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P: Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 128:608–615, 1996
Kitagawa T, Owada M, Urakami T, Yamauchi K: Increased incidence of NIDDM among Japanese school children correlates with an increased intake of animal protein and fat. Clin Pediatr (Phila) 37:111–115, 1998
Dabelea D, Hanson RL, Bennett PH, Roumain J, Knowler WC, Pettitt DJ: Increasing prevalence of Type II diabetes in American Indian children. Diabetologia 41:904–910, 1998
Kim C, McHugh C, Kwok Y, Smith A: Type 2 diabetes mellitus in Navajo adolescents. West J Med 170:210–213, 1999
Wise E, Kolb E, Sauder S: Effect of glycemic control on growth velocity in children with IDDM. Diabetes Care 15:826–830, 1992
Danne T, Weber B, Hartman R, Enders I, Burger W, Hovener G: Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Diabetes Care 17:1390–1396, 1994
Donaghue KC, Fung A, Hing S, Fairchild J, King J, Chain A, Howard NJ, Silink M: The effect of prepubertal diabetes duration on diabetes. Diabetes Care 20:77–80, 1997
Weissberg-Benchell J, Glasgow AM, Tynan WD, Wirtz P, Turek J, Ward J: Adolescent diabetes management and mismanagement. Diabetes Care 18:77–82, 1995
Brink SJ, Moltz, K: The message of the DCCT for children and adolescents. Diabetes Spectrum 10:259–267, 1997
American Diabetes Association: Type 2 diabetes in children and adolescents (Consensus Statement). Diabetes Care 23:381–389, 2000
Food and Nutrition Board, National Research Council: Recommended Dietary Allowances, 10th ed, Washington, DC, National Academy Press, 1989, p. 285
Position of the American Dietetic Association: Dietary guidance for healthy children aged 2 to 11 years. J Am Diet Assoc 99:93–101, 1999
Expert Panel on Blood Cholesterol Levels in Children and Adolescents: Treatment recommendations of the National Cholesterol Education Program report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 89 (Suppl.):525–584, 1992
U.S. Department of Agriculture: The Food Guide Pyramid. Hyattsville, MD, USDA Human Nutrition Information Service, 1992
Centers for Disease Control/National Center for Health Statistics: U.S. Growth Charts, 2000: Available from http://www.cdc.gov/growthcharts. Accessed November 2000
American Academy of Pediatrics Committee on Nutrition: Cholesterol in children. Pediatrics 101:141–147, 1998
Williams CL, Bollella M, Wynder EL: A new recommendation for dietary fiber in childhood. Pediatrics 96:985–988, 1995
Andersen RE, Crespo CJ, Bartlett SJ, Cheskin LJ, Pratt M: The relationship of physical activity and television watching with body weight and level of fatness among children. JAMA 279:938–942, 1998
Austin A, Warty V, Janosky J, Arslanian S: The relationship of physical fitness to lipid and lipoprotein(a) levels in adolescents with IDDM. Diabetes Care 16:421–425, 1993
Ferguson MA, Gutin B, Le N-A, Karp W, Litaker M, Humphries M, Okuyama T, Riggs S, Owens S: Effects of exercise training and its cessation on components of the insulin resistance syndrome in obese children. Int J Obes Relat Metab Disord 23:889–895, 1999
McClain MR, Srinivassan SR, Chen W, Steinmann WC, Berenson GS: Risk of type 2 diabetes mellitus in young adults from a biracial community: the Bogalusa Heart Study. Prev Med 31:1–7, 2000
Cogswell ME, Serdula MK, Hungerford DW, Yip R: Gestational weight gain among average-weight and overweight women. What is excessive? Am J Obstet Gynecol 172:705–712, 1995
Edwards LE, Hellerstedt WL, Alton IR, Story M, Himes JH: Pregnancy complications and birth outcomes in obese and normal-weight women: effects of gestational weight change. Obstet Gynecol 87:389–394, 1996
Food and Nutrition Board: Recommended Dietary Allowances. 10th ed. Washington, DC, National Academy of Sciences, 1989, p. 59–62
Kaplan JS, Iqbal S, England BG, Zawacki CM, Herman WH: Is pregnancy in diabetic women associated with folate deficiency? Diabetes Care 22:1017–1021, 1999
ACOG Committee on Obstetrics: Folic acid and the prevention of recurrent neural tube defects. Int J Gynaecol Obstet 42:75–77, 1993
Department of Health and Human Services, Public Health Service: Recommendation for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 41(RR-14):1–7, 1992
Czeizel AE: Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ 306:1645–1648, 1993
Shaw GM, Lammer EJ, Wasserman CR, O’Malley CD, Tolarova MM: Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptually. Lancet 346:393–397, 1995
Scholl TO, Hediger ML, Schall JI, Fischer RL, Khoo CS: Low zinc intake during pregnancy: its association with preterm and very preterm delivery. Am J Epidemiol 137:1115–1124, 1993
Goldenberg RL, Tamura T, Neggers Y, Copper RL, Johnston KE, Du Bard MB, Hauth JC: The effect of zinc supplementation on pregnancy outcome. JAMA 274:463–468, 1995
American Dietetic Association: Position of the American Dietetic Association: Use of nutritive and nonnutritive sweeteners. J Am Diet Assoc 98:580–587, 1998
The American Dietetic Association: Nutrition Practice Guidelines for Gestational Diabetes Mellitus. Available from http://eatright.com. Accessed October 2001
Pitkin RM, Reynolds WA, Filer LJ, Kling TG: Placental transmission and fetal distribution of saccharin. Am J Obstet Gynecol 111:280–286, 1971
London RS, Rorick Jr, JT: Safety evaluation in pregnancy. In The Clinical Evaluation of a Food Additive: Assessment of Aspartame. Tschanz C, Butchko HH, Stargel WW, Kotsonis FN, Eds. New York, Marcel Dekker, 2001, p. 115–123
Pitkin RM: Aspartame ingestion during pregnancy. In Aspartame. Stegink LD, Filer LJ, Eds. New York, Marcel Dekker, 1984, p. 555–563
Sturtevant FM: Use of aspartame during pregnancy (Review). Int J Fertil 30:85–87, 1985
London R: Saccharin and aspartame. Are they safe to consume during pregnancy? J Reprod Med 33:17–21, 1988
Grice HC, Goldsmith LA: Sucralose: an overview of the toxicity data. Food Chem Toxicol 38(Suppl. 2):S1–S6, 2000
The Diabetes Control and Complications Trial Research Group: Pregnancy outcomes in the Diabetes Control and Complications Trial. Am J Obstet Gynecol 174:1343–1353, 1996
Gestational diabetes. ACOG Practice Bulletin No. 30. American College of Obstetricians and Gynecologists. Obstet Gynecol 98:525–538, 2001
Rizzo T, Metzger BE, Burns WJ, Burns K: Correlations between antepartum maternal metabolism and intelligence of offspring. N Engl J Med 325:911–916, 1991
Rizzo TA, Dooley SL, Metzger BE, Cho NH, Ogata ES, Silverman BL: Prenatal and perinatal influences on long-term psychomotor development in offspring of diabetic mothers. Am J Obstet Gynecol 173:1753–1758, 1995
American Diabetes Association: Proceedings of the Fourth International Workshop: Conference on Gestational Diabetes Mellitus. Diabetes Care 21(Suppl. 2):B161−B167, 1998
McFarland MB, Langer O, Conway DL, Berkus MD: Dietary therapy for gestational diabetes. How long is long enough? Obstet Gynecol 93:978–982, 1999
Mello G, Parretti E, Mecacci F, Carbone C, Lucchetti R, Lagazio C, Pratesi M, Scarselli G: Anthropometric features in infants of mothers with gestational diabetes: relationship with treatment modalities. Biol Neonate 72:22–27, 1997
Langer O, Conway DL, Backus MD, Xenakis EMJ, Gonzales O: The comparison of glyburide and insulin in women with gestational diabetes. N Engl J Med 343:1134–1138, 2000
Garcia-Patterson A, Corcoy R, Balsells M, Altirriba O, Adelantado JM, Cabero L, De Leiva A: In pregnancies with gestational diabetes mellitus and intensive therapy, perinatal outcome is worse in small-for-gestational-age newborns. Am J Obstet Gynecol 179:481–485, 1998
Peterson CH, Jovanovic-Peterson L: Percentage of carbohydrate and glycemic response to breakfast, lunch, and dinner in women with gestational diabetes. Diabetes 40(Suppl. 2):172–174, 1991
Major CA, Henry MJ, DeVeciana M, Morgan MA: The effects of carbohydrate restriction in patients with diet-controlled gestational diabetes. Obstet Gynecol 91:600–604, 1998
Jovanovic-Peterson L, Peterson CM: Dietary manipulation as primary treatment strategy for pregnancies complicated by diabetes. J Am Coll Nutr 9:320–325, 1990
Clapp JF: Effect of dietary carbohydrate on the glucose and insulin response to mixed caloric intake and exercise in both nonpregnant and pregnant women. Diabetes Care 21(Suppl. 2):B107−B112, 1998
Gunderson EP: Intensive nutrition therapy for gestational diabetes: rationale and current issues. Diabetes Care 20:221–226, 1997
Maggee MS, Knopp RH, Benedetti TJ: Metabolic effects of 1200 kcal diet in obese pregnant women with gestational diabetes. Diabetes 39:234–240, 1990
Knopp RH, Magee MS, Raisys V, Benedetti T, Bonet B: Hypocaloric diets and ketogenesis in the management of obese gestational diabetic women. J Am Coll Nutr 10:649–667, 1991
Snyder J, Gray-Donald K, Koski KG: Predictors of infant birth weight in gestational diabetes. Am J Clin Nutr 59:1409–1414, 1994
Jovanovic-Peterson L (Ed.): Medical Management of Pregnancy Complicated by Diabetes. 3rd ed. Alexandria, VA, American Diabetes Association, 2000
Avery MD, Leon AS, Kopher RA: Effects of a partially home-based exercise program for women with gestational diabetes. Obstet Gynecol 89:10–15, 1997
Combs CA, Gunderson E, Kitzmiller JL, Gavin LA, Main EK: Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care 15:1251–1257, 1992
De Veciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, Evans AT: Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 333:1237–1241, 1995
Gunderson E, Adams B: Epidemiology of gestational weight gain and body weight change after pregnancy. Epidemiol Rev 21:261–275, 1999
Murtaugh MA, Ferris AM, Capacchione CM, Reese EA: Energy intake and glycemia in lactating women with type 1 diabetes. J Am Diet Assoc 98:642–648, 1998
American Diabetes Association: Gestational diabetes mellitus (Position Statement). Diabetes Care 25(Suppl. 1):S94–S96, 2002
Institute of Medicine: Nutrition During Lactation. Washington, DC, National Academy Press, 1991
Mooradian AD: Biology of aging. In Rehabilitation of the Aging and Elderly Patient. Felsenthal G, Garrison SJ, Steinberg FU, Eds. Baltimore, MD, Williams & Wilkins, 1994, p. 3–10
Reed RL, Mooradian AD: Nutritional status and dietary management of elderly patients with diabetes. Clin Geriatr Med 6:883–901, 1990
Mooradian AD, McLaughlin S, Boyer CC, Winter J: Diabetes care for older adults. Diabetes Spectrum 12:70–77, 1999
Millward DJ, Fereday A, Gibson N, Pacy PJ: Aging, protein requirements and protein turnover. Am J Clin Nutr 66:774–786, 1997
Roberts SB, Fuss P, Heyman MB, Young VR: Influence of age on energy requirements. Am J Clin Nutr 62 (Suppl.):1053S−1058S, 1995
Visser M, Deurenberg P, van Staveren WA, Hautrat JG: Resting metabolic rate and diet-induced thermogenesis in young and elderly subjects: relationship with body composition, fat distribution, and physical activity level. Am J Clin Nutr 61:772–778, 1995
Mooradian AD, Osterweil D, Petrasek D, Morley JE: Diabetes mellitus in elderly nursing home patients: a survey of clinical characteristics and management. J Am Geriatr Soc 36:391–396, 1988
Morley JE, Mooradian AD, Silver AJ, Heber D, Alfin-Slater RB: Nutrition in the elderly. Ann Intern Med 109:890–904, 1988
Morais JA, Gougeon R, Pencharz PB, Jones PJ, Ross R, Marlish EM: Whole body protein turnover in the healthy elderly. Am J Clin Nutr 66:880–889, 1997
Toth MJ, Arciero PJ, Gardner AW, Calles-Escandon J, Poehlman ET: Rates of free fatty acid appearance and fat oxidation in healthy younger and older men. J Appl Physiol 80:506–511, 1996
Roberts SB, Fuss P, Dallal GE, Atkinson A, Evans WJ, Joseph L, Fiatarone MA, Greenberg AS, Young VR: Effects of age on energy expenditure and substrate oxidation during experimental overfeeding in healthy men. J Gerontol 51:B142–B157, 1996
Roberts SB, Fuss P, Heyman MB, Dallal GE, Young VR: Effects of age on energy expenditure and substrate oxidation during experimental underfeeding in healthy men. J Gerontol 51:B158–B166, 1996
Coulston AM, Mandelbaum D, Reaven GM: Dietary management of nursing home residents with non-insulin dependent diabetes mellitus. Am J Clin Nutr 51:62–71, 1990
American Diabetes Association: Translation of the diabetes nutrition recommendations for health care institutions. Diabetes Care 25(Suppl. 1):S61–S63, 2002
Schafer R, Bohannon B, Franz MJ, Freeman J, Holmes A, McLaughlin S, Haas L, Kruger D, Lorenz R, McMahon M: Translation of the diabetes nutrition recommendations for health care institutions (Technical Review). Diabetes Care 20:96–105, 1997
Pannemans DL, Van den Berg H, Westerterp KR: The influence of protein intake on Vitamin B6 metabolism differs in young and elderly humans. J Nutr 124:1207–1214, 1994
Lindenbaum J, Rosenberg IH, Wilson PWF, Stabler SP, Allen RH: Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 60:2–11, 1994
Koehler KM, Pareo-Tubbeh SL, Romero LJ, Baumgartner RN, Garry PJ: Folate nutrition and older adults: challenges and opportunities. J Am Diet Assoc 97:167–173, 1997
Lindeman RD, Romero LJ, Kohler KM, Liang HC, LaRue A, Baumgartner RN, Garry PJ: Serum Vitamin B12, C and folate concentrations in the New Mexico elder health survey: correlations with cognitive and affective functions. J Am Coll Nutr 19:68–76, 2000
Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693–2698, 1993
Lindenbaum J, Healton EB, Savage DG, Brust JC, Garrett TJ, Podell ER, Marcell PD, Stabler SP, Allen RH: Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocystosis. N Engl J Med 318:1720–1728, 1988
Kinyamu HK, Gallagher JC, Balhorn KE, Petranick KM, Rafferty KA: Serum vitamin D metabolites and calcium absorption in normal young and elderly free living women and women living in nursing homes. Am J Clin Nutr 65:790–797, 1992
Volkert D, Kruse W, Oster P, Schlierf G: Malnutrition in geriatric patients: diagnostic and prognostic significance of nutritional parameters. Ann Nutr Metab 36:97–112, 1992
Hallfrisch J, Muller DC: Does diet provide adequate amounts of calcium, iron, magnesium and zinc in a well educated adult population? Exp Gerontol 28:473–483, 1993
Hallfrisch J, Muller DC, Singh VN: Vitamin A and E intakes and plasma concentrations of retinal, beta-carotene and alpha tocopherol in men and women of the Baltimore Longitudinal Study of Aging. Am J Clin Nutr 60:176–182, 1994
Selhub J, Jacques PF, Bostom AG, D’Agostino RB, Wilson PW, Belanger AJ, O’Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH: Association between plasma homocysteine concentrations and extracranial carotid artery disease. N Engl J Med 332:286–291, 1995
Amato P, Morales AJ, Yen SSC: Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese older men and women. J Gerontol 55A:M250–M263, 2000
Hagberg JM: Effect of training on the decline of Vo2max with aging. Fed Proc 46:1830–1833, 1987
LaCroix AZ, Leveille SG, Hecht JA, Grothaus LC, Wagner EH: Does walking decrease the risk of cardiovascular disease hospitalizations and death in older adults? J Am Geriatr Soc 44:113–120, 1996
Schwartz RS: Exercise training in treatment of diabetes mellitus in elderly patients. Diabetes Care 13 (Suppl 2):77–85, 1990
Clark WL, Cox DJ, Gonder-Frederick L, Julian D, Kovatchev B, Young-Hyman D: Biopsychobehavioral model of risk of severe hypoglycemia. Diabetes Care 22:580–584, 1999
Brodows RG, Williams C, Amatruda JM: Treatment of insulin reactions in diabetics. JAMA 252:3378–3381, 1984
Wiethop BV, Cryer PE: Alanine and terbutaline in the treatment of hypoglycemia in IDDM. Diabetes Care 16:1131–1136, 1993
Schvarcz E, Palmer M, Aman J, Berne C: Hypoglycemia increases the gastric emptying rate in healthy subjects. Diabetes Care 18:674–676, 1995
Levy CJ, Kinsley BT, Bajaj M, Simonson DC: Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM. Diabetes Care 21:1330–1338, 1998
Dinneen S, Gerich J, Rizza: Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 327:707–713, 1992
Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrara MG, Cahill GF: Brain metabolism during fasting. J Clin Invest 46:1589–1595, 1967
Cahill GF, Owen OE, Felig P: Insulin and fuel homeostasis. Physiologist 11:97–102, 1968
Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S, Cutler JA, the TONE Collaborative Research Group: Sodium restriction and weight loss in the treatment of hypertension in older person: a randomized controlled trial of nonpharmacologic intervention in the elderly. JAMA 279:839–846, 1998
Wylie-Rosett J, Wassertheil-Smoller S, Blaufox MD, Davis BR, Langford HG, Oberman A, Jennings S, Hataway H, Stern J, Zimbaldi N: Trial of Antihypertensive Intervention and Management: a greater efficacy with weight reduction than with a sodium-potassium intervention. J Am Diet Assoc 93:408–414, 1993
Wassertheil-Smoller S, Blaufox D, Oberman A, Langford HG: Adequate weight loss alone and combined with drug therapy in the treatment of mild hypertension. Arch Intern Med 152:131–136, 1993
Trial of Hypertension Prevention Collaborative Research Group: The effects on nonpharmacological intervention on blood pressure of persons with high normal blood levels: results of the Trial of Hypertension Prevention Phase I. JAMA 267:1213–1220, 1992
Kotchen TA, Kotchen JM: Dietary sodium and blood pressure: interactions with other nutrients. Am J Clin Nutr 65 (Suppl.):708S−711S, 1997
Hamet P, Mongeau E, Lambert J, Bellavance F, Daignault-Gelinas M, Ledour M: Interactions among calcium, sodium, and alcohol intake as determinants of blood pressure. Hypertension 17(Suppl. 1):I150–I154, 1991
Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ: Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials. JAMA 277:1624–1632, 1997
Hamet P: The evaluation of the scientific evidence for a relationship between calcium and hypertension. J Nutr 125 (Suppl.):311S−411S, 1995
Gruchow HW, Sobocinski KA, Barboriak JJ: Calcium intake and the relationship of dietary sodium and potassium to blood pressure. Am J Clin Nutr 48:1463–1470, 1988
McCarron DA, Reusser ME: Nonpharmacologic therapy in hypertension: from single components to overall dietary management. Prog Cardiovasc Dis 41:451–460, 1999
Tuck M, Corry D, Trujillo A: Salt-sensitive blood pressure and exaggerated vascular reactivity in the hypertension of diabetes mellitus. Am J Med 88:210–216, 1991
Imanishi M, Yoshioka K, Okumura M, Konishi Y, Okada N, Morikawa T, Sato T, Tanaka S, Fujii S: Sodium sensitivity related to albuminuria appearing before hypertension in type 2 patients with diabetes. Diabetes Care 24:111–116, 2001
Cutler JA, Follmann D, Allender PS: Randomized trials of sodium reduction: an overview. Am J Clin Nutr 65(Suppl. 1):643S−651S, 1997
Midgley JP, Matthew AG, Greenwood CMT, Logan AG: Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA 275:1590–1597, 1996
Alam S, Johnson AG: A meta-analysis of randomised controlled trials (RCT) among healthy normotensive and essential hypertensive elderly patients to determine the effect of high salt (NaCl) diet on blood pressure. J Hum Hypertens 13:367–374, 1999
Sacks FM, Obarzanek E, Windhauser MM, Svetkey LP, Vollmer WM, McCullough M, Karanja N, Lin PH, Steele P, Proschan MA: Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH): a multi-center controlled-feeding study of dietary patterns to lower blood pressure. Ann Epidemiol 5:108–118, 1995
Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetky LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N, the DASH Collaborative Research Group: A clinical trial of the effects of dietary pattern on blood pressure. N Engl J Med 336:1117–1124, 1997
Svetkey LP, Simons-Morton D, Vollmer WM, Appel LJ, Conlin PR, Ryan DH, Ard J, Kennedy BM for the DASH Collaborative Research Group: Effects of dietary patterns of blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med 159:285–293, 1999
Sacks FM, Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Bray GA: Dietary approaches to prevent hypertension: a review of the Dietary Approaches to Stop Hypertension (DASH) Study. Clin Cardiol 22 (Suppl.):III6−10, 1999
Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG, Karanja N, Lin P-H for the DASH-Sodium Collaborative Research Group: Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 344:3–10, 2001
Staessen J, Fagard R, Lijnen P, Amery A: Body weight, sodium intake, and blood pressure. J Hypertens 7 (Suppl.):S19−S23, 1989
Puddey IB, Beilin LJ, Vandongen R, Rouse IL, Rogers P: Evidence for a direct effect of alcohol consumption on blood pressure in normotensive men: a randomized controlled trial. Hypertension 7:707–713, 1985
Puddey IB, Beilin LJ, Vandongen R: Regular alcohol use raises blood pressure in treated hypertensive subjects: a randomized controlled trial. Lancet i:647–651, 1987
World Hypertension League: Alcohol and hypertension: implications for management. A consensus statement by the World Hypertension League. J Hum Hypertens 5:227–232, 1991
Allender PS, Cutler JA, Follmann D, Cappuccio PP, Pryer J, Elliott P: Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Ann Intern Med 124:825–831, 1996
Feingold KR, Grunfield C, Pang M, Doerrler W, Krauss RM: LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb Vasc Biol 12:1496–1502, 1992
Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP Jr, Mayer EF, Krauss RM: LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 88:381–387, 1993
Haffner SM, Mykkanen L, Stern MP, Paidi M, Howard BV: Greater effect of diabetes on LDL size in women than in men. Diabetes Care 17:1164–1171, 1994
Singh AT, Rainwater DL, Haffner SM, VandeBerg JL, Shelledy WR, Moore PH Jr, Dyer TD: Effect of diabetes on lipoprotein size. Arterioscler Thromb Vasc Biol 15:1805–1811, 1995
Siegel RD, Cupples A, Schaefer EJ, Wilson PW: Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study. Metabolism 45:1267–1272, 1996
Temelkova-Kurktschiev T, Hanefeld M, Leonhardt W: Small dense low-density lipoprotein (LDL) in non-insulin-dependent diabetes mellitus (NIDDM): impact of hypertriglyceridemia. Ann N Y Acad Sci 827:279–286, 1997
Fujimoto WY, Abbate SL, Kahn SE, Hokanson JE, Brunzell JD: The visceral adiposity syndrome in Japanese-American men. Obes Res 2:364–371, 1994
Tchernof A, Lamarche B, Prud’Homme D, Nadeau A, Moorjani S, Labrie F, Lupian PJ: The dense LDL phenotype: association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 19:629–637, 1996
Rönnemaa T, Mattila K, Lehtonen A, Kallio V: A controlled randomized study on the effect of long-term physical exercise on metabolic control in type 2 patients. Acta Med Scand 220:219–224, 1986
Weinsier RL, Seeman A, Herrera MG, Assal JP, Soeldner JS, Gleason RE: High- and low-carbohydrate diets in diabetes mellitus: study of effects on diabetic control, insulin secretion, and blood lipids. Ann Intern Med 80:332–341, 1974
Kiehm TG, Anderson TW, Ward K: Beneficial effects of a high carbohydrate, high fiber diet on hyperglycemic diabetic men. Am J Clin Nutr 29:895–899, 1976
Anderson JW, Ward K: High-carbohydrate, high fiber diets for insulin-treated men with diabetes mellitus. Am J Clin Nutr 32:2312–2321, 1979
Howard BV, Abbott WG, Swinburn BA: Evaluation of metabolic effects of substitution of complex carbohydrates for saturated fat in individuals with obesity and NIDDM. Diabetes Care 14:786–795, 1991
Coulston AM, Hollenbeck CB, Swislocki ALM, Chen Y-DI, Reaven G: Deleterious metabolic effects of high-carbohydrate, sucrose-containing diets in patients with non-insulin-dependent diabetes mellitus. Am J Med 82:213–220, 1987
Coulston AM, Hollenbeck CB, Swislocki ALM, Reaven GM: Persistence of hypertriglyceridemic effect of low-fat high-carbohydrate diets in NIDDM patients. Diabetes Care 12:94–101, 1989
Grundy SM, Baldy GJ, Criqui MH, Fletcher G, Greenland P, Hiratzka LF, Houston-Miller N, Kris-Etherton P, Krumholz HM, LaRosa J, Ockene IS, Pearson TA, Reed J, Smith SC, Washington R: When to start cholesterol-lowering therapy in patients with coronary heart disease: a statement for healthcare professionals from the American Heart Association task force on risk reduction. Circulation 95:1683–1685, 1997
Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G: Cholesterol lowering with simvastatin improves prognosis of patients with diabetes with coronary heart disease. Diabetes Care 20:614–620, 1997
Goldberg RB, Mellies MJ, Sacks FM, Moye LA, Howard BV, Howard WJ, Davis BR, Cole TG, Pfeffer MA, Braunwald E: Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation 98:2513–2519, 1998
Elkeles RS, Diamond JR, Poulter C, Dhanji S, Nicolaides AN, Mahmood S, Richmond W, Mather H, Sharp P, Feher MD: Cardiovascular outcomes in type 2 diabetes: a double-blind placebo- controlled study of bezafibrate. The St. Mary’s, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study. Diabetes Care 21:641–648, 1998
Chait A, Brunzell JD: Chylomicronemia syndrome. Adv Intern Med 37:249–273, 1992
Santamarina-Fojo S: The familial chylomicronemia syndrome. Endocrinol Metab Clin North Am 27:551–567, viii, 1998
Elam MB, Hunninghake DB, Davis KB, Garg R, Johnson C, Egan D, Kostis JB, Sheps DS, Brinton EA: Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease. The ADMIT study: a randomized trial. Arterial Disease Multiple Intervention Trial. JAMA 284:1263–1270, 2000
American Diabetes Association: Diabetic nephropathy (Position Statement). Diabetes Care 25(Suppl. 1):S85–S89, 2002
Tapp DC, Wortham WG, Addison JF, Hammonds DN, Barnes JL, Venkatachalam MA: Food restriction retards body growth and prevents end-stage renal pathology in remnant kidneys of rats regardless of protein intake. Lab Invest 60:184–194, 1989
Kobayashi S, Venkatachalam MA: Differential effects of caloric restriction on glomeruli and tubules of the remnant kidney. Kidney Int 42:710–717, 1992
Allen TJ, Waldron MJ, Casley D, Jerums G, Cooper ME: Salt restriction reduces hyperfiltration, renal enlargement and albuminuria in experimental diabetes. Diabetes 46:19–24, 1997
Craven PA, DeRubertis FR, Kagan VE, Melhem M, Studer RK: Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-β1, and glomerular size in diabetes. J Am Soc Nephrol 8:1405–1411, 1997
Koya D, Lee IK, Ishii H, Kanoh H, King GL: Prevention of glomerular dysfunction in diabetic rats by treatment of d-α-tocopherol. J Am Soc Nephrol 8:426–435, 1997
Bouhanick B, Suraniti S, Berrut G, Bled F, Simard G, Lejeune JJ, Fressinaud P, Marre M: Relationship between fat intake and glomerular filtration rate in normotensive insulin-dependent patients with diabetes. Diabetes Metab 21:168–172, 1995
Pijls LTJ, deVries H, Donker AJM, vanEijk JTM: The effect of protein restriction on albuminuria in patients with type 2 diabetes mellitus: a randomized trial. Nephrol Dial Transplant 14:1445–1453, 1999
Pomerleau J, Verdy M, Garrel DR, Nadeau MH: Effect of protein intake on glycaemic control and renal function in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:829–834, 1993
Hansen HP, Christensen PK, Tauber-Lassen E, Klausen A, Jenen BR, Parving HH: Low-protein diet and kidney function in insulin-dependent patients with diabetes with diabetic nephropathy. Kidney Int 55:621–628, 1999
Dullaart RPF, vanDoormaal JJ, Beusekamp BJ, Sluiter WJ, Meijer S: Long-term effects of protein-restricted diet on albuminuria and renal function in IDDM patients without clinical nephropathy and hypertension. Diabetes Care 2:483–492, 1993
Raal FJ, Kalk WJ, Lawson M, Esser JD, Buys R, Fourie L, Panz VR: Effect of moderate dietary protein restriction on the progression of overt diabetic nephropathy: a 6-month prospective study. Am J Clin Nutr 60:579–585, 1994
Ciavarella A, DiMizio G, Stefoni S, Borgnino LC, Vannini P: Reduced albuminuria after dietary protein restriction in insulin-dependent patients with diabetes with clinical nephropathy. Diabetes Care 10:407–413, 1987
Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR: Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 324:78–84, 1991
Walker JD, Bending JJ, Dodds RA, Mattock MB, Murrells TJ, Keen H, Viberti GC: Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet i i:1411–1415, 1989
Pecis M, DeAzevedo MJ, Gross JL: Chicken and fish diet reduces glomerular hyperfiltration in IDDM patients. Diabetes Care 17:665–672, 1994
Jibani MM, Bloodworth LL, Foden E, Griffiths KD, Galpin OP: Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: effects on albumin excretion rate and nutritional status. Diabet Med 8:949–953, 1991
Barsotti G, Ciardella F, Morelli E, Cupisti A, Mantovanelli A, Giovannetti S: Nutritional treatment of renal failure in type 1 diabetic nephropathy. Clin Nephrol 29:280–287, 1988
Kontessis PS, Trevisan R, Bossinakou I, Roussi D, Sarika L, Stipsanelli K, Iliopoulou E, Grigorakis S, Papantoniou A, Souvatzoglou A: Renal, metabolic, and hormonal responses to proteins of different origin in normotensive, nonproteinuric type 1 diabetic subjects. Diabetes Care 18:1233–1240, 1995
McMahon MM, Farnell MB, Murray MJ: Nutritional support of critically ill patients. Mayo Clin Proc 68:911–920, 1993
McMahon MM: Nutrition support and diabetes. In American Diabetes Association Guide to Medical Nutrition Therapy for Diabetes. Franz MJ, Bantle JP, Eds. Alexandria, VA, American Diabetes Association, 2000, p. 335–348
Peters AL, Davidson MB: Effects of various enteral feeding products on postprandial blood glucose response in patients with type 1 diabetes. JPEN J Parenter Enteral Nutr 16:69–74, 1992
Harris MI, Hadden WC, Knowler WC, Bennett PH: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in the US population aged 20–74 years. Diabetes Care 36:523–534, 1987
Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults: the Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care 21:518–524, 1998
Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP: The continuing epidemics of obesity and diabetes in the United States. JAMA 12:1195–1200, 2001
Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett-Connor EL, Dowse GK, Haffner SM, Pettitt DJ, Sorkin JD, Muller DC, Collins VR, Hamman RF: Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46:701–710, 1997
Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL: Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 272:205–211, 1994
Eriksson J, Lindstrom J, Valle T, Aunola S, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Lauhkonen M, Lehto P, Lehtonen A, Louheranta A, Mannelin M, Martikkala V, Rastas M, Sundvall J, Turpeinen A, Viljanen T, Uusitupa M, Tuomilehto J: Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention program. Diabetologia 42:793–801, 1999
Wing RR: Physical activity in the treatment of adulthood overweight and obesity: current evidence and research issues. Med Sci Sports Exerc 31 (Suppl.):S547–S552, 1999
Apfelbaum M, Vague P, Ziegler O, Hanotin C, Thomas F, Leutenegger E: Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine. Am J Med 106:179–184, 1999
Hauptman J, Lucas C, Boldrin MN, Collins H, Segal KR: Orlistat in the long-term treatment of obesity in primary care settings. Arch Fam Med 9:160–167, 2000
Rossner S, Sjostrom L, Noack R, Meinders AE, Noseda G: Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity: European Orlistat Obesity Study Group. Obes Res 8:49–61, 2000
National Heart Lung and Blood Institute Expert Panel: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 6(Suppl. 2):102S−125S, 1998
Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. Diabetes Care 20:537–544, 1997
Eriksson KF, Lindgarde F: Prevention of type 2 (non-insulin dependent) diabetes mellitus by diet and physical exercise. Diabetologia 34:891–898, 1991
Viswanathan M, Snehalatha C, Viswanathan V, Vidyavathi P, Indu J, Ramachandran A: Reduction in body weight helps to delay the onset of diabetes even in non-obese with strong family history of the disease. Diabetes Res Clin Pract 35:107–112, 1997
Heymsfield SB, Segal KR, Hauptman J, Lucas CP, Boldrin MN, Rissanen A, Wilding JP, Sjostrom L: Effects of weight loss with Orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Arch Intern Med 160:1321–1326, 2000
Sjostrom CD, Lissner L, Weedel H, Sjostrom L: Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 5:477–484, 1999
Moore LL, Visioni AJ, Wilson PW, D’Agostino RB, Finkle WD, Ellison RC: Can sustained weight loss in overweight individuals reduce the risk of diabetes mellitus? Epidemiology 3:269–273, 2000
Wannamethee SG, Shaper AG: Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 22:1266–1272, 1999
Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC: Diet, lifestyle and the risk of type 2 diabetes mellitus in women. N Engl J Med 345:790–797, 2001
Wing RR, Goldstein M, Acton K, Birch L, Jakicic JM, Sallis JF, Smith-West D, Jeffrey R, Surwit R: Lifestyle changes related to obesity, eating behavior, and physical activity. Diabetes Care 24:117–123, 2001
Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS Jr: Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325:147–152, 1991
Frisch RE, Wyshak G, Albright E, Albright NL, Schiff I: Lower prevalence of diabetes in female former college athletes compared with nonathletes. Diabetes 35:1101–1105, 1986
Manson JE, Rimm EB, Stampfer MJ, Colditz GA, Willett WC, Krolewski AS, Rosner B, Hennekens CH, Speizer FE: Physical activity and incidence of non-insulin-dependent diabetes in women. Lancet 338:774–778, 1991
Manson JE, Nathan DM, Krolewski AS, MJ Stampfer MJ, Willett WC, Hennekens CH: A prospective study of exercise and incidence of diabetes among US male physicians. JAMA 268:63–67, 1992
Perry IJ, Wannamethee M, Walker MK, Thomson AG, Whincup PH, Shaper AG: Prospective study of risk factors for development of non-insulin-dependent diabetes in middle aged British men. BMJ 310:560–564, 1995
Kohl HW, Gordon NF, Villegas JA, Blair SN: Cardiorespiratory fitness, glycemic status, and mortality risk in men. Diabetes Care 15:185–192, 1992
Lee DC, Blair SN, Jackson AS: Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am J Clin Nutr 69:373–380, 1999
Tsunehara CH, Leonetti DL, Fujimoto WY: Diet of second-generation Japanese-American men with and without non-insulin-dependent diabetes. Am J Clin Nutr 52:731–738, 1990
Meyer KA, Kushi LH, Jacobs DR, Folsom AR: Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care 24:1528–1535, 2001
Hughes VA, Fiatarone MA, Fielding RA, Ferrara CM, Elahi D, Evans WJ: Long-term effects of a high-carbohydrate diet and exercise on insulin action in older subjects with impaired glucose tolerance. Am J Clin Nutr 62:426–433, 1995
Louheranta AM, Turpeinen AK, Vidgren HM, Schwab US, Uusitupa MI: A high-trans fatty acid diet and insulin sensitivity in young healthy women. Metabolism 48:870–875, 1999
Sarkkinen E, Schwab U, Niskanen L, Hannuksela M, Savolainen M, Kervinen K, Kesniemi A, Uusitupa MI: The effects of monounsaturated-fat enriched diet and polyunsaturated-fat enriched diet on lipid and glucose metabolism in subjects with IGT. Eur J Clin Nutr 50:592–598, 1996
Ahren B, Gudbjartsson T, Al-Amin AM, Martensson H, Myrsen-Axcrona U, Karlsson S, Mulder H, Sundler F: Islet perturbations in rats fed a high-fat diet. Pancreas 18:75–83, 1999
Larsson H, Elmstahl S, Beglund G, Ahren B: Habitual dietary intake versus glucose tolerance, insulin sensitivity and insulin secretion in postmenopausal women. J Intern Med 245:581–591, 1999
Mayer-Davis EJ, Levin S, Bergman RN, D’Agostino RB Jr, Karter AJ, Saad MF: Insulin secretion, obesity, and potential behavioral influences: results from the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Metab Res Rev 17:137–145, 2001
Wolever TM, Hamad S, Gittelsohn J, Gao J, Hanley AJ, Harris SB, Zinman B: Low dietary fiber and high protein intakes associated with newly diagnosed diabetes in a remote aboriginal community. Am J Clin Nutr 66:1470–1474, 1997
Meyer KA, Kushi LH, Jacobs DR Jr, Slavin J, Sellers TA, Folsom AR: Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 71:921–930, 2000
Paolisso G, D’Amore A, Giugliano D, Ceriello A, Varricchio M, D’Onofrio F: Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent patients with diabetes. Am J Clin Nutr 57:650–656, 1993
Reunanen A, Knekt P, Aaran R-K, Aromaa A: Serum antioxidants and risk of non-insulin dependent diabetes mellitus. Eur J Clin Nutr 52:89–93, 1998
Lukaksi HC: Magnesium, zinc, and chromium nutriture and physical activity. Am J Clin Nutr 72 (Suppl.):585S−593S, 2000
Singh RB, Niaz MA, Rastogi SS, Bajaj S, Gaoli Z, Shoumin Z: Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am Coll Nutr 17:564–570, 1998
Hypponen E, Kenward MG, Virtanen SM, Piitulainen A, Virta-Autio P, Tuomilehto J, Knip M, Akerblom HK: Infant feeding, early weight gain, and risk of type 1 diabetes: Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 22:1961–1965, 1999
Norris JM, Scott FW: A meta-analysis of infant diet and insulin-dependent diabetes mellitus. Do biases play a role? Epidemiology 7:87–92, 1996
Meloni T, Marinaro AM, Mannazzu MC, Ogana A, La Vecchia C, Negri E, Colombo C: IDDM and early infant feeding: Sardinian case-control study. Diabetes Care 20:340–342, 1997
Vaarala O, Knip M, Paronen J, Hamalainan AM, Muona P, Vaatainen M, Ilonan J, Simell O, Akerblom HK: Cow’s milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes 48:1389–1394, 1999
Virtanen SM, Hypponen E, Laara E, Vahasalo P, Kulmala P, Savola K, Rasanen L, Aro A, Knip M, Akerblom HK: Cow’s milk consumption, disease-associated autoantibodies and type 1 diabetes mellitus: a follow-up study in siblings of diabetic children. Childhood Diabetes in Finland Study Group. Diabet Med 15:730–738, 1998
Bodington MJ, McNally PG, Burden AC: Cow’s milk and type 1 childhood diabetes: no increase in risk. Diabet Med 11:663–665, 1994